Mercoledi dalle ore 13 alle ore 14 e 30 previo appuntamento 

Francesco Cappelli, medico, Specialista in Cardiologia, PhD in Scienze Cliniche, e' attualmente ricercatore a tempo determinato tipologia B, settore scientifico disciplinare MED/11 presso il Dipartimento di Medicina Sperimentale e Clinica della Universita' degli studi di Firenze. Responsabile dell'ambulatorio cardiologico del Centro di Riferimento Toscano per la Cura della Amiloidosi presso la Azienda Ospedaiero Universitaria di Careggi.  

Francesco Cappelli

Telephone Number: +39 3382504484

E-mail:f.cappelli@unifi.it

DOB: 13 Luglio 1979

1 novembre 2021 ad oggi

Ricercatore a tempo determinato tipologia B settore scientifico disciplinare MED/11 presso l'Università di Firenze (in accordo all’articolo 10 comma 8 lettera B ai sensi della legge 240 del 2010). Cardiologo in convenzione presso l'Azienda Ospedaliero Universitaria Careggi, nel reparto di Terapia Cardiaca Intensiva. SOD Interventistica Cardiologica Strutturale, Largo Brambilla 3, 50134 Firenze

 Gennaio 2010 ad oggi

Cardiologo di riferimento del Centro regionale di riferimento per l'amiloide della Toscana Azienda Ospedaliera Universitaria Careggi Università di Firenze: diagnosi di amiloidosi cardiaca, gestione della terapia, networking con altri professionisti dell'amiloidosi dell'AOUC e con altri centri di riferimento principalmente CNR (Pisa), Sant'Orsola (Bologna), Ospedale San Matteo (Pavia), Ospedale Sant'Andrea Sapienza (Roma), National Amyloid Center royal free Hospital (Londra).

Formazione scolastica

Facoltà di Medicina: Università degli Studi di Firenze, 1998-2004, voto massimo e lode

Specializzazione in Cardiologia: Università di Firenze, 2005-2008, punteggio pieno e lode

Certificazione: Collegio Italiano di Cardiologia, 2008

Dottorato in Scienze Cliniche Università degli Studi di Firenze 2019-2021

Formazione ed esperienze lavorative pregresse

Luglio-agosto 2003

Formazione in cardiologia presso il Beth Israel Deaconess Medical Center Harvard Medical School of medicine Boston MA, USA.

Giugno 2004-dicembre 2009

Tirocinio post-laurea presso il Laboratorio di Ecocardiografia tenuto dalla Dott.ssa M.C. Porciani Azienda Ospedialiera Universitaria Careggi Università di Firenze

Gennaio 2007-dicembre 2009

Tirocinio post-laurea presso il Centro regionale toscano di riferimento per l'amiloide Azienda Ospedialiera Universitaria Careggi Università di Firenze tenuto dal Dott. Franco Bergesio e Dott. Federico Perfetto

Ottobre 2008-novembre 2009

 Vincitore di una borsa di ricerca della durata di un anno della “Società Italiana per l’Amiloidosi” con un progetto “Utilità dell’imaging Tissue Doppler per la diagnosi precoce del coinvolgimento cardiaco nell’amiloidosi sistemica”

Gennaio 2010 fino al 30 ottobre 2021

Cardiologo presso l'Azienda Ospedaliero Universitaria Careggi, nel reparto di Terapia Cardiaca Intensiva. SOD Interventistica Cardiologica Strutturale, Largo Brambilla 3, 50134

Pubblicazioni su riviste indicizzate sottoposte a revisione

Total citation = 2,655 (Scopus)

Hirsch  index (H-index)= 27   (Scopus)

1. Macioce, R., Cappelli. F., Demarchi, G., Lilli, A., Ricciardi, G., Pieragnoli, P., Colella, A., Michelucci, A., Porciani, M. C., Padeletti, L. Resynchronization of mitral valve annular segments reduces functional mitral regurgitation in cardiac resynchronization therapy. Minerva Cardioangiol. 2005 Aug;53(4):329-33
2. M.C. Porciani, R. Macioce, G. Demarchi, M. Chiostri, N. Musilli, F. Cappelli, A. Lilli, G. Ricciardi  L. Padeletti  Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure. Eur J Echocardiogr2006 Jan;7(1):31-9
3. Porciani MC, Lilli A, Macioce R, Cappelli F, Demarchi G, Pappone A, Ricciardi G, Padeletti L.Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy.Eur Heart J. 2006 Aug;27(15):1818-23.
4. Porciani MC, Dondina C, Macioce R, Demarchi G, Cappelli F, Lilli A, Pappone A, Ricciardi G, Colombo PC, Padeletti M, Jelic S, Padeletti L.Temporal variation in optimal atrioventricular and interventricular delay during cardiac resynchronization therapy. J Card Fail. 2006 Dec;12(9):715-9.
5. Cappelli F, Ermini FR, Del Pace S, Micheli S, Gensini GF. Favourable outcome of  streptococcus agalactiae prosthetic valve endocarditis after conservative treatment. Int J Cardiol. 2007 Jan 8;114(2):E73-4.
6. Porciani MC, Rao CM, Mochi M, Cappelli F, Bongiorno G, Perini AP, Ricciardi G, Hastroudi L, Silvestri P,Barold SS, Padeletti L. A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. Pacing Clin Electrophysiol 2008 Jan(1):56-63.
7. Cappelli F, Lazzeri C, Gensini GF, Valente S.Cannabis: a trigger for acute myocardial infarction? A case report J Cardiovasc Med 2008 9:725-728
8. Berni A, Cappelli F, Bitossi L, Cecioni I, Cappelli B, Toncelli L, Galanti G, Poggesi L. Non-invasive tissue Doppler imaging pulmonary capillary wedge pressure measurement improves NT-proBNP prognostic value in heart failure. Acta Cardiol.2009 Apr;64(2):213-8.
9. Porciani, M. C., Lilli, A., Perfetto, F., Cappelli, F., Rao, C. M., Del Pace, S., Ciaccheri, M., Castelli, G., Tarquini, R., Romagnani, L., Pastorini, T., Padelletti, L., Bergesio, F. Tissue Doppler and Strain Imaging: a new tool for early detection of cardiac amyloidosis? Amyloid, June 2009 Vol 16 (2) 63-70
10. Cappelli F, Valente S, Gensini GF. Is it time to consider cannabis smoking a cardiovascular risk factor? J Cardiovasc Med (Hagerstown). 2009 Oct;10(10):745-6.
11. Porciani CM, Lilli A, Cappelli F, Pappone A, Perini AP, Pieragnoli P, Ricciardi G, Rao CM, Prinzen FW, Michelucci A, Padeletti L.Echo/Doppler-derived  time intervals are able to predict left ventricular reverse remodeling after cardiac resynchronization therapy. J Cardiovasc Med (Hagerstown). 2009 Oct 16.
12. Padeletti L, Valleggi A, Vergaro G, Lucà F, Rao CM, Perrotta L, Cappelli F, L'Abbate A, Passino C, Emdin M. Concordant versus discordant left bundle branch block in heart failure patients: novel clinical value of an old electrocardiographic diagnosis. J Card Fail. 2010 Apr;16(4):320-6. doi: 10.1016/j.cardfail.2009.12.005. Epub 2010 Jan 18. PMID: 20350699.
13. Cappelli F, Toncelli L, Cappelli B, De Luca A, Stefani L, Maffulli N, Galanti G. Adaptative or maladaptative hypertrophy, different spatial distribution of myocardial contraction. Clin Physiol Funct Imaging. 2010 Jan;30(1):6-12. doi: 10.1111/j.1475-097X.2009.00896.x
14. Porciani MC, Cappelli F, Perrotta L, Chiostri M, Rao CM, Pieragnoli P, Ricciardi G, Michelucci A, Jelic S, Padeletti L. Has mechanical dyssynchrony still a role in predicting cardiac resynchronization therapy response? Echocardiography. 2010 Aug;27(7):831-8. doi: 10.1111/j.1540-8175.2009.01133.x
15. Cappelli F, Vignini S, Baldereschi GJ. ALN inferior vena cava filter upside down rotation with chest caval migration in an asymptomatic patient. J InvasiveCardiol. 2010 Aug;22(8):E153-5
16. Cappelli F, Cristina Porciani M, Ricceri I, Perrotta L, Ricciardi G,Pieragnoli P, Paladini G, Michelucci A, Padeletti L. Tricuspid annular planesystolic excursion evaluation improves selection of cardiac resynchronizationtherapy patients. Clin Cardiol. 2010 Sep;33(9):578-82. doi: 10.1002/clc.20806
17. Porciani MC, Cappelli F, Perfetto F, Ciaccheri M, Castelli G, Ricceri I,Chiostri M, Franco B, Padeletti L. Rotational mechanics of the left ventricle in AL amyloidosis. Echocardiography. 2010 Oct;27(9):1061-8. doi: 10.1111/j.1540-8175.2010.01199.x.
18. Cappelli F, Porciani MC, Bergesio F, Perfetto F, De Antoniis F, Cania A, Tronconi F, Ricceri I, Padeletti L. Characteristics of left ventricular rotational mechanics in patients with systemic amyloidosis, systemic hypertension and normal left ventricular mass. Clin Physiol Funct Imaging. 2011Mar;31(2):159-65. doi: 10.1111/j.1475-097X.2010.00987.x.
19. Cappelli F, Del Bene MR, Barletta G. Three-dimensional transesophageal evaluation of prosthetic perivalvular leak. G Ital Cardiol (Rome). 2010Nov;11(11):860
20. Perfetto F, Cappelli F, Bergesio F. Asymptomatic homozygous gene carrier in afamily with Ile68Leu ATTR amyloidosis: a new endemic region in northern Tuscany? J Cardiovasc Med (Hagerstown). 2011 Jun;12(6):450-1. doi:10.2459/JCM.0b013e3283464e12.
21. Cappelli F, Del Bene MR, Santoro G, Meucci F, Attanà P, Barletta G. The challenge of integrated echocardiographic approach in percutaneous closure ofparavalvular leak. Echocardiography. 2011 Sep;28(8):E168-71. doi:10.1111/j.1540-8175.2011.01444.x.
22. Perfetto F, Porciani MC, Cappelli F. Rotational mechanics of the leftventricle in amyloid light chain amyloidosis. Am J Cardiol. 2011 Dec1;108(11):1686-7. doi: 10.1016/j.amjcard.2011.08.018.
23. Del Bene MR, Cappelli F, Rega L, Venditti F, Barletta G. Characterization of  Löeffler eosinophilic myocarditis by means of real time three-dimensionalcontrast-enhanced echocardiography. Echocardiography. 2012 Mar;29(3):E62-6. doi: 10.1111/j.1540-8175.2011.01570.x.
24. Cappelli F, Porciani MC, Bergesio F, Perlini S, Attanà P, Moggi Pignone A, Salinaro F, Musca F, Padeletti L, Perfetto F. Right ventricular function in ALamyloidosis: characteristics and prognostic implication. Eur Heart J CardiovascImaging. 2012 May;13(5):416-22. doi: 10.1093/ejechocard/jer289.
25. Cappelli F, Favilli S, Ricciardi G, Pieragnoli P, Padeletti L. Atrial standstill disease progression documented after 13 years follow-up. Intern Emerg Med. 2012 May;7 Suppl 1:S7-8. doi: 10.1007/s11739-011-0519-5.
26. Smorti M, Cappelli F, Bergesio F, Perfetto F. Anxiety and depression among ALamyloidosis patients: the role of cardiac symptoms. Amyloid. 2012Sep;19(3):123-8. doi: 10.3109/13506129.2012.687420.
27. Rapezzi C, Quarta CC, Obici L, Perfetto F, Longhi S, Salvi F, Biagini E, Lorenzini M, Grigioni F, Leone O, Cappelli F, Palladini G, Rimessi P, Ferlini A,  Arpesella G, Pinna AD, Merlini G, Perlini S. Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. Eur Heart J. 2013 Feb;34(7):520-8 doi: 10.1093/eurheartj/ehs123.
28. Perfetto  F, Cappelli F, Bergesio F, Ciuti G, Porciani MC, Padeletti L, Moggi  Pignone A. Cardiac amyloidosis: the heart of the matter. Intern Emerg Med. 2013Apr;8(3):191-203. doi: 10.1007/s11739-011-0647-y
29. Cappelli F, Perlini S, Attanà P, Ciuti G, Salinaro F, Perfetto F. As we cannot afford to renounce to new generation echocardiography in systemic amyloidosis. Amyloid. 2013 Sep;20(3):195-6. doi: 10.3109/13506129.2013.808993.
30. Perlini S, Salinaro F, Cappelli F, Perfetto F, Bergesio F, Alogna A, Mussinelli R, Boldrini M, Raimondi A, Musca F, Palladini G, Merlini G. Prognostic value of fragmented QRS in cardiac AL amyloidosis. Int J Cardiol. 2013 Sep 1;167(5):2156-61. doi: 10.1016/j.ijcard.2012.05.097.
31. Cappelli F, Padeletti L, Acquafresca M, Pignone AM, Perfetto F. Repeated systemic thromboembolism in a patient with severe cardiac AL amyloidosis without  evidence of atrial fibrillation. Intern Emerg Med. 2014 Mar;9(2):243-5. doi: 10.1007/s11739-013-0960-8.
32. Smorti M, Cappelli F, Guarnieri S, Bergesio F, Perfetto F. Depression and cardiac symptoms among AL amyloidosis patients: the mediating role of coping strategies. Psychol Health Med. 2014;19(3):263-72. doi: 10.1080/13548506.2013.802357.
33. Perfetto F, Bergesio F, Emdin M, Cappelli F. Troponins in cardiac amyloidosis: multipurpose markers. Nat Rev Cardiol. 2014 Mar;11(3):179. doi: 10.1038/nrcardio.2013.129-c1.
34. Perlini S, Salinaro F, Musca F, Mussinelli R, Boldrini M, Raimondi A, Milani P, Foli A, Cappelli F, Perfetto F, Palladini G, Rapezzi C, Merlini G. Prognostic  value of depressed midwall systolic function in cardiac light-chain amyloidosis.  J Hypertens. 2014 May;32(5):1121-31; discussion 1131. doi: 10.1097/HJH.0000000000000120.
35. Cappelli F, Baldasseroni S, Bergesio F, Padeletti L, Attanà P, Pignone AM, Grifoni E, Ciuti G, Fabbri A, Tarantini F, Marchionni N, Gensini GF, Perfetto F.  Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. Amyloid. 2014 Jun;21(2):97-102. doi: 10.3109/13506129.2014.884971.
36. Aquaro GD, Pugliese NR, Perfetto F, Cappelli F, Barison A, Masci PG, Passino C, Emdin M. Myocardial signal intensity decay after gadolinium injection: a fast  and effective method for the diagnosis of cardiac amyloidosis. Int J Cardiovasc Imaging. 2014 Aug;30(6):1105-15. doi: 10.1007/s10554-014-0436-6.
37. Smorti A, Cappelli F, Zarantonello R, Tani F, Gensini GF. Medical error and systems of signaling: conceptual and linguistic definition. Intern Emerg Med. 2014 Jul 18. PubMed PMID: 25034521.
38. Attanà P, Paoletti Perini A, Votta CD, Cappelli F, Pieragnoli P, Ricciardi G,  Nesti M, Giomi A, Sacchi S, Chiostri M, Padeletti L. QRS duration in left bundle branch block does not affect left ventricular twisting in chronic systolic heart failure. Clin Physiol Funct Imaging. 2014 Jul 31. doi: 10.1111/cpf.12181. [Epubahead of print] PubMed PMID: 25077412.
39. Barison A, Aquaro GD, Pugliese NR, Cappelli F, Chiappino S, Vergaro G, Mirizzi G, Todiere G, Passino C, Masci PG, Perfetto F, Emdin M. Measurement of myocardialamyloid deposition in systemic amyloidosis: insights from cardiovascular magneticresonance imaging. J Intern Med. 2014 Oct 24. doi: 10.1111/joim.12324. [Epubahead of print] PubMed PMID: 25346163.
40. Smorti M, Guarnieri S, Bergesio F, Perfetto F, Cappelli F. Anxiety anddepression among amyloid light-chain cardiac amyloidosis patients: The role oflife satisfaction. Eur J Cardiovasc Nurs. 2015 Jan 19. pii: 1474515114566737.[Epub ahead of print] PubMed PMID: 25601945.
41. Cappelli F, Baldasseroni S, Bergesio F, Perlini S, Salinaro F, Padeletti L,Attanà P, Paoletti Perini A, Moggi Pignone A, Grifoni E, Fabbri A, Marchionni N, Gensini GF, Perfetto F. chocardiographic and Biohumoral Characteristics in Patients With AL and TTR Amyloidosis at Diagnosis. Clin Cardiol. 2015Feb;38(2):69-75. doi: 10.1002/clc.22353.. PubMed PMID: 25645201.
42. Perfetto F, Frusconi, S, Bergesio F,Giforni, E, Fabbri, A, Giuliani, C, Falconi, S, Bonifacio, S , Cappelli, F (2015). The Val142Ile transthyretin cardiac amyloidosis: more than an Afro-American pathogenic variant. JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERPECTIVES, vol. 5, p. 26931, ISSN: 2000-9666
43. Neglia D, Rovai D, Caselli C, Pietila M, Teresinska A, Aguadé-Bruix S, Pizzi MN, Todiere G, Gimelli A, Schroeder S, Drosch T, Poddighe R, Casolo G, Anagnostopoulos C, Pugliese F, Rouzet F, Le Guludec D, Cappelli F, Valente S,Gensini GF, Zawaideh C, Capitanio S,Sambuceti G, Marsico F, Perrone Filardi P,Fernández-Golfín C, Rincón LM, Graner FP, de Graaf MA, Fiechter M, Stehli J,Gaemperli O, Reyes E, Nkomo S, Mäki M, Lorenzoni V, Turchetti G, Carpeggiani C,Marinelli M, Puzzuoli S, Mangione M, Marcheschi P, Mariani F, Giannessi D, Nekolla S, Lombardi M, Sicari R, Scholte AJ, Zamorano JL, Kaufmann PA, Underwood  SR, Knuuti J; EVINCI Study Investigators. Detection of significant coronaryartery disease by noninvasive anatomical and functional imaging. Circ Cardiovasc Imaging. 2015 Mar;8(3). pii: e002179. doi: 10.1161/CIRCIMAGING.114.002179. PubMedPMID: 25711274.
44. Cappelli F, Frusconi S, Bergesio F, Grifoni E, Fabbri A, Giuliani C, Falconi S, Bonifacio S, Perfetto F. The Val142Ile transthyretin cardiac amyloidosis: not only an afro American pathogenic variant? A single center Italian experience. Journal of Cardiovascular Medicine 2016 Feb;17(2):122-5.44)
45. Perfetto F, Bergesio F, Grifoni E, Fabbri A, Ciuti G, Frusconi S, Angelotti P, Spini V, Cappelli F. Different NT-proBNP circulating levels for different types of cardiac amyloidosis. J Cardiovasc Med (Hagerstown). 2016 Jan 12.. [Epub ahead of print]
46. : Liga R, Vontobel J, Rovai D, Marinelli M, Caselli C, Pietila M, Teresinska A, Aguadé-Bruix S, Pizzi MN, Todiere G, Gimelli A, Chiappino D, Marraccini P, Schroeder S, Drosch T, Poddighe R, Casolo G, Anagnostopoulos C, Pugliese F,Rouzet F, Le Guludec D, Cappelli F, Valente S, Gensini GF, Zawaideh C, Capitanio S, Sambuceti G, Marsico F, Filardi PP, Fernández-Golfín C, RincÃn LM, Graner FP, de Graaf MA, Stehli J, Reyes E, Nkomo S, MÃki M, Lorenzoni V, Turchetti G,Carpeggiani C, Puzzuoli S, Mangione M, Marcheschi P, Giannessi D, Nekolla S,Lombardi M, Sicari R, Scholte AJ, Zamorano JL, Underwood SR, Knuuti J, KaufmannPA, Neglia D, Gaemperli O; EVINCI Study Investigators. Multicentre multi-devicehybrid imaging study of coronary artery disease: results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of IschaemicHeart Disease (EVINCI) hybrid imaging population. Eur Heart J Cardiovasc Imaging.2016 Mar 18. pii: jew038. [Epub ahead of print] Review. PubMed PMID: 26992419.
47. Cappelli F, Baldasseroni S, Bergesio F, Spini V, Fabbri A, Angelotti P, Grifoni E, Attanà P, Tarantini F, Marchionni N, Moggi Pignone A, Perfetto F. Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system. Intern Emerg Med. 2017 Feb;12(1):23-30. doi: 10.1007/s11739-016-1500-0
48. Scarpino M, Lanzo G, Cappelli F, Moretti M, Misuri G, Voltolini L, Pistolesi M, Amantini A, Grippo A. Cerebral Fat Embolism After Video-Assisted Thoracic Surgery. Ann Thorac Surg. 2016 Nov;102(5):e409-e411. doi: 10.1016/j.athoracsur.2016.04.073.
49. Tomberli B, Cappelli F, Perfetto F, Olivotto I. Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy. JAMA Cardiol. 2017 Jan 1;2(1):94-97. doi: 10.1001/jamacardio.2016.3894.
50. Cappelli F, Gallini C, Di Mario C, Costanzo EN, Vaggelli L, Tutino F, Ciaccio  A, Bartolini S, Angelotti P, Frusconi S, Farsetti S, Vergaro G, Giorgetti A, Marzullo P, Genovesi D, Emdin M, Perfetto F. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis. J  Nucl Cardiol. 2017 May 23. doi: 10.1007/s12350-017-0922-z.
51. Cappelli F, Morini S, Pieragnoli P, Targetti M, Stefàno P, Marchionni N, Olivotto I. Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria. J Am Coll Cardiol. 2018 Jan 30;71(4):464-466. doi: 10.1016/j.jacc.2017.11.040.
52. Cappelli F, Gallini C, Costanzo EN, Tutino F, Ciaccio A, Vaggelli L, Bartolini S, Morini S, Martone R, Angelotti P, Frusconi S, Di Mario C, Perfetto F. Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon. Int J Cardiol. 2018 Mar 1;254:346-350.
53. Cappelli F, Martone R, Taborchi G, Morini S, Bartolini S, Angelotti P, Farsetti S, Di Mario C, Perfetto F. Epigallocatechin-3-gallate tolerability and impact on survival in a cohort of patients with transthyretin-related cardiac amyloidosis. A single-center retrospective study. Intern Emerg Med. 2018 Jun 7. doi: 10.1007/s11739-018-1887-x.
54. Agostini C, Stolcova M, Bernardo P, Cappelli F, Sori A, Mattesini A, Meucci F, Sorini Dini C, Cianchi G, Peris A, Di Mario C, Valente S. Tips and tricks for using extracorporeal life support devices in the intensive cardiac care unit. G  Ital Cardiol (Rome). 2018 Jun;19(6):14-22. doi: 10.1714/2939.29546.
55. Gagliardi C, Perfetto F, Lorenzini M, Ferlini A, Salvi F, Milandri A, Quarta CC, Taborchi G, Bartolini S, Frusconi S, Martone R, Cinelli MM, Foffi S, Reggiani MLB, Fabbri G, Cataldo P, Cappelli F, Rapezzi C. Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure. Eur J Heart  Fail. 2018 Aug 2. doi: 10.1002/ejhf.1285.
56. Gallini C, Tutino F, Martone R, Ciaccio A, Costanzo EN, Taborchi G, Morini S,  Bartolini S, Farsetti S, Di Mario C, Perfetto F, Cappelli F. Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy. J Nucl Cardiol. 2019 Feb 14. doi: 10.1007/s12350-019-01643-w.
57. Martone R, Marchionni N, Cappelli F. Heart failure with mid-range ejection fraction: Current evidence and uncertainties. Monaldi Arch Chest Dis. 2019 Apr 8;89(1). doi: 0.4081/monaldi.2019.1024. PubMed PMID: 30968665.
58. Lorenzoni V, Bellelli S, Caselli C, Knuuti J, Underwood SR, Neglia D, Turchetti G, Pietila M, Mäki M, Teresinska A, Aguadé-Bruix S, Pizzi MN, Todiere G, Gimelli A, Lombardi M, Puzzuoli S, Mangione M, Marcheschi P, Schroeder S, Drosch T, Poddighe R, Casolo G, Anagnostopoulos C, Pugliese F, Rouzet F, Le Guludec D, Cappelli F, Valente S, Gensini GF, Zawaideh C, Capitanio S, Sambuceti G, Marsico F, Filardi PP, Fernández-Golfín C, Rincón LM, Zamorano JL, Graner FP, Nekolla S, de Graaf MA, Scholte AJHA, Fiechter M, Stehli J, Gaemperli O, Kaufmann PA, Reyes E, Nkomo S, Carpeggiani C, Giannessi D, Mariani F, Marinelli M, Sicari R (2019). Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS, vol. 20, p. 1437-1449, ISSN: 1618-7601, doi: 10.1007/s10198-019-01096-5
59. Cappelli F, Gallini C, Perfetto F. PYP or DPD and HDP for cardiac amyloidosis one for all, all for one. J Nucl Cardiol. 2019 May 1. doi: 10.1007/s12350-019-01728-6. [Epub ahead of print] PubMed PMID: 31044407
60. Canepa M, Tini G, Musumeci B, Cappelli F, Milandri A, Mussinelli R, Autore C,  Perfetto F, Rapezzi C, Perlini S. Real-world versus trial patients with transthyretin amyloid cardiomyopathy. Eur J Heart Fail. 2019 Nov;21(11):1479-1481. doi: 10.1002/ejhf.1563. Epub 2019 Jul 24. PubMed PMID:31339212.
61. Chacko L, Martone R, Cappelli F, Fontana M. Cardiac Amyloidosis: Updates in Imaging. Curr Cardiol Rep. 2019 Aug 2;21(9):108. doi: 10.1007/s11886-019-1180-2.  Review. PubMed PMID: 31375984; PubMed Central PMCID: PMC6677705.
62. Martone R, Perfetto F, Cappelli F. A Man in His 80s With Hypertension, Left Ventricular Hypertrophy, and Enlarged Biceps. JAMA Cardiol. 2019 Oct 16. doi:10.1001/jamacardio.2019.3899. [Epub ahead of print] PubMed PMID: 31617859.
63. Musumeci MB, Cappelli F, Russo D, Tini G, Canepa M, Milandri A, Bonfiglioli R, Di Bella G, My F, Luigetti M, Grandis M, Autore C, Perlini S, Perfetto F, Rapezzi C. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2019 Dec 18. pii: S1936-878X(19)31012-5. doi: 10.1016/j.jcmg.2019.10.015. [Epub ahead of print] PubMed PMID: 31864976.
64. Boldrini M, Cappelli F, Chacko L, Restrepo-Cordoba MA, Lopez-Sainz A, GiannoniA, Aimo A, Baggiano A, Martinez-Naharro A, Whelan C, Quarta C, Passino C,Castiglione V, Chubuchnyi V, Spini V, Taddei C, Vergaro G, Petrie A,Ruiz-Guerrero L, Moñivas V, Mingo-Santos S, Mirelis JG, Dominguez F,Gonzalez-Lopez E, Perlini S, Pontone G, Gillmore J, Hawkins PN, Garcia-Pavia P,Emdin M, Fontana M. Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2019 Dec 18. pii: S1936-878X(19)31007-1. doi: 10.1016/j.jcmg.2019.10.011. [Epub ahead of print]PubMed PMID: 31864973.
65. Cappelli F, Martone R, Gabriele M, Taborchi G, Morini S, Vignini E, Allinovi M, Di Gioia M, Bartolini S, Di Mario C, Perfetto F. Biomarkers and Prediction of  Prognosis in Transthyretin-Related Cardiac Amyloidosis: Direct Comparison of Two Staging Systems. Can J Cardiol. 2020 Mar;36(3):424-431. doi: 10.1016/j.cjca.2019.12.020. Epub 2019 Dec 30. PubMed PMID: 32145869.
66. Chacko L, Martone R, Bandera F, Lane T, Martinez-Naharro A, Boldrini M, Rezk T, Whelan C, Quarta C, Rowczenio D, Gilbertson JA, Wongwarawipat T, Lachmann H, Wechalekar A, Sachchithanantham S, Mahmood S, Marcucci R, Knight D, Hutt D, Moon J, Petrie A, Cappelli F, Guazzi M, Hawkins PN, Gillmore JD, Fontana M. Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.Eur Heart J. 2020 Jan 17. pii: ehz905. doi: 10.1093/eurheartj/ehz905. [Epub ahead of print] PubMed PMID: 31950987.
67. Cappelli F, Vignini E, Martone R, Perlini S, Mussinelli R, Sabena A, Morini S, Gabriele M, Taborchi G, Bartolini S, Lossi A, Nardi G, Marchionni N, Di Mario C, Olivotto I, Perfetto F. Baseline ECG Features and Arrhythmic Profile in Transthyretin Versus Light Chain Cardiac Amyloidosis. Circ Heart Fail. 2020 Mar;13(3):e006619. doi: 10.1161/CIRCHEARTFAILURE.119.006619.
68. Di Filippo C, Caniato F, Cappelli F, Mattesini A, Meucci F, Sori A, Stolcova M, Agostini C, Bernardo P, Di Mario C. Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty: a case report. J Cardiovasc Med (Hagerstown). 2020 Jul 17. doi: 10.2459/JCM.0000000000001042.
69. Cappelli F, Perfetto F, Martone R, Di Mario C. Cardiac amyloidosis in patient undergoing TAVR, why we need to think about it. Cardiovasc Revasc Med. 2020 Jun 10:S1553-8389(20)30354-7. doi: 10.1016/j.carrev.2020.06.005.
70. Russo M, Obici L, Bartolomei I, Cappelli F, Luigetti M, Fenu S, Cavallaro T, Chiappini MG, Gemelli C, Pradotto LG, Manganelli F, Leonardi L, My F, Sampaolo S, Briani C, Gentile L, Stancanelli C, Di Buduo E, Pacciolla P, Salvi F, Casagrande S, Bisogni G, Calabrese D, Vanoli F, Di Iorio G, Antonini G, Santoro L, Mauro A, Grandis M, Di Girolamo M, Fabrizi GM, Pareyson D, Sabatelli M, Perfetto F, Rapezzi C, Merlini G, Mazzeo A, Vita G. ATTRv amyloidosis Italian Registry: clinical and epidemiological data. Amyloid. 2020 Jul 22:1-7. doi:10.1080/13506129.2020.1794807.
71. Ciabatti M, Fumagalli C, Beltrami M, Vignini E, Martinese L, Tomberli A, Zampieri M, Bertini A, Carrassa G, Marchi A, Berteotti M, Cappelli F, Bolognese L, Pieroni M, Olivotto I. Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy. Int J Cardiol. 2020 Nov 1;318:94-100. doi: 10.1016/j.ijcard.2020.07.036.
72. Antonioli E, Staderini M, Pilerci S, Perfetto F, Cappelli F, Allinovi M,Nozzoli C, Attucci I, Buzzichelli A, Messeri M, Bosi A. Daratumumab,lenalidomide, and dexamethasone combination in relapsed/refractory myelomapatients: a real-life single-center experience. Leuk Lymphoma. 2020 Aug 10:1-4.doi: 10.1080/10428194.2020.1802452.
73. Bartolini S, Baldasseroni S, Fattirolli F, Silverii MV, Piccioli L, Perfetto F, Marchionni N, Di Mario C, Martone R, Taborchi G, Morini S, Vignini E, Cappelli F. Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients.Intern Emerg Med. 2020 Sep 12. doi: 10.1007/s11739-020-02474-1.
74. Pontecorboli G, Lagi F, Bagli M, De Vito E, Millotti G, Botta A, Cappelli F, Mattesini A, Acquafresca M, Barletta G, Del Bene R, Colagrande S, Marcucci R, Bartoloni A, Di Mario C, Martinelli CV. Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients. Infez Med. 2020 Sep 1;28(3):397-406.
75. Perfetto F, Casagrande S, Barilaro A, Di Gioia M, Santi R, Allinovi M, Romoli S, Boschi A, Desideri I, Taborchi G, Ungar A, Cappelli F. Progressive and atypical neurological symptoms in refractory systemic AL amyloidosis. Intern Emerg Med. 2020 Sep 14. doi: 10.1007/s11739-020-02489-8.
76. Cappelli F, Tini G, Russo D, Emdin M, Del Franco A, Vergaro G, Di Bella G, Mazzeo A, Canepa M, Volpe M, Perfetto F, Autore C, Di Mario C, Rapezzi C, Musumeci MB. Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation. Amyloid. 2020 Sep 28:1-7. doi: 10.1080/13506129.2020.1798922.
77. Aquaro GD, Morini S, Grigoratos C, Taborchi G, Di Bella G, Martone R, Vignini E, Emdin M, Olivotto I, Perfetto F, Cappelli F. Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates. Int J Cardiol Heart Vasc. 2020 Sep 14;31:100633. doi: 10.1016/j.ijcha.2020.100633.
78. Zampieri M, Nardi G, Del Monaco G, Allinovi M, Gabriele M, Zocchi C, Casagrande S, Fumagalli C, Di Mario C, Olivotto I, Perfetto F, Cappelli F. Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany. Int J Cardiol. 2021 Apr 15:S0167-5273(21)00659-8. doi: 10.1016/j.ijcard.2021.04.023. Epub ahead of print. PMID: 33865873.
79. Magliano L, Obici L, Sforzini C, Mazzeo A, Russo M, Cappelli F, Fenu S, Luigetti M, Tagliapietra M, Gemelli C, Leonardi L, Tozza S, Pradotto LG, Citarelli G, Mauro A, Manganelli F, Antonini G, Grandis M, Fabrizi GM, Sabatelli M, Pareyson D, Perfetto F, Merlini G, Vita G; ATTRv Collaborators. Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy. Orphanet J Rare Dis. 2021 Apr 7;16(1):163. doi: 10.1186/s13023-021-01812-6. PMID: 33827635; PMCID: PMC8028211.
80. Zampieri M, Cappelli F, Allinovi M, Olivotto I, Antonioli E, Tassetti L, Zocchi C, Andrei V, Di Mario C, Nozzoli C, Curciarello G, Ciciani AM, Bergesio F, Vannucchi AM, Perfetto F. Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study. Amyloid. 2021 Mar 10:1-2. doi: 10.1080/13506129.2021.1898365. Epub ahead of print. PMID: 33715557.
81. Cappelli F, Zampieri M, Fumagalli C, Nardi G, Del Monaco G, Matucci Cerinic M, Allinovi M, Taborchi G, Martone R, Gabriele M, Ungar A, Moggi Pignone A, Marchionni N, Di Mario C, Olivotto I, Perfetto F. Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype. J Intern Med. 2021 Jun;289(6):831-839. doi: 10.1111/joim.13200. Epub 2020 Dec 8. PMID: 33615623.
82. Grandis M, Obici L, Luigetti M, Briani C, Benedicenti F, Bisogni G, Canepa M, Cappelli F, Danesino C, Fabrizi GM, Fenu S, Ferrandes G, Gemelli C, Manganelli F, Mazzeo A, Melchiorri L, Perfetto F, Pradotto LG, Rimessi P, Tini G, Tozza S, Trevisan L, Pareyson D, Mandich P. Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus. Orphanet J Rare Dis. 2020 Dec 14;15(1):348. doi: 10.1186/s13023-020-01633-z.
83. Girolami F, Vergaro G, Pieroni M, Passantino S, Giannotti G, Grippo G, Canale ML, Favilli S, Cappelli F, Olivotto I, Casolo G. Percorso clinico proposto dall’ANMCO Toscana per la diagnosi genetica delle cardiomiopatie in un sistema assistenziale in rete [Clinical pathway for cardiomyopathies: a genetic testing strategy proposed by ANMCO in Tuscany]. G Ital Cardiol (Rome). 2020 Dec;21(12):926-934. Italian. doi: 10.1714/3472.34547.
84. Argirò A, Zampieri M, Berteotti M, Marchi A, Tassetti L, Zocchi C, Iannone L, Bacchi B, Cappelli F, Stefàno P, Marchionni N, Olivotto I. Emerging Medical Treatment for Hypertrophic Cardiomyopathy. J Clin Med. 2021 Mar 1;10(5):951. doi: 10.3390/jcm10050951. PMID: 33804412; PMCID: PMC7957690.
85. Zampieri M, Allinovi M, Olivotto I, Antonioli E, Gabriele M, Argirò A, Fumagalli C, Nardi G, Di Mario C, Vannucchi AM, Perfetto F, Cappelli F. Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? Br J Haematol. 2021 May;193(4):e27-e31. doi: 10.1111/bjh.17399. Epub 2021 Apr 11. PMID: 33840100.
86. Zampieri M, Nardi G, Del Monaco G, Allinovi M, Gabriele M, Zocchi C, Casagrande S, Fumagalli C, Di Mario C, Olivotto I, Perfetto F, Cappelli F. Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany. Int J Cardiol. 2021 Jul 15;335:123-127. doi: 10.1016/j.ijcard.2021.04.023. Epub 2021 Apr 15. PMID: 33865873.
87. Aimo A, Rapezzi C, Perfetto F, Cappelli F, Palladini G, Obici L, Merlini G, Di Bella G, Serenelli M, Zampieri M, Milani P, Licordari R, Teresi L, Ribarich N, Castiglione V, Quattrone F, De Rosis S, Vergaro G, Panichella G, Emdin M, Passino C. Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis. Eur J Clin Invest. 2021 Nov;51(11):e13598. doi: 10.1111/eci.13598. Epub 2021 May 22. PMID: 33982288.
88. Tini G, Cappelli F, Biagini E, Musumeci B, Merlo M, Crotti L, Cameli M, Di Bella G, Cipriani A, Marzo F, Guerra F, Forleo C, Gagliardi C, Zampieri M, Carigi S, Vianello PF, Mandoli GE, Ciliberti G, Lichelli L, Mariani D, Porcari A, Russo D, Licordari R, Ponziani A, Porto I, Perfetto F, Autore C, Rapezzi C, Sinagra G, Canepa M. Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey. ESC Heart Fail. 2021 Aug;8(4):3369-3374. doi: 10.1002/ehf2.13411. Epub 2021 May 14.
89. Zampieri M, Berteotti M, Ferrantini C, Tassetti L, Gabriele M, Tomberli B, Castelli G, Cappelli F, Stefàno P, Marchionni N, Coppini R, Olivotto I. Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives. Curr Heart Fail Rep. 2021 Aug;18(4):169-179. doi: 10.1007/s11897-021-00523-0. Epub 2021 Jun 20. PMID: 34148184.
90. Emdin M, Perfetto F, Aimo A, Vergaro G, Buda G, Cappelli F, Pieroni M, Grippo G, Sorini Dini C, Canale ML, Olivotto I, Cameli M, Casolo G. Percorso clinico-assistenziale in rete per la diagnosi e la gestione del paziente con amiloidosi cardiaca. Documento di consenso ANMCO Toscana e SIC Tosco-Umbra [Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC)]. G Ital Cardiol (Rome). 2021 Aug;22(8):621-634. Italian. doi: 10.1714/3641.36218.
91. Caniato F, Andrei V, Bernardo P, Agostini C, Cappelli F, Stefano PL, Olivotto I, Pieroni M, Bolognese L, Di Mario C. Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy Plus Apical Ballooning: Management With VA-ECMO and Myectomy. JACC Case Rep. 2021 Mar 17;3(3):433-437. doi: 10.1016/j.jaccas.2020.11.029. PMID: 34317552; PMCID: PMC8311032.
92. Fumagalli C, Zampieri M, Perfetto F, Zocchi C, Maurizi N, Tassetti L, Ungar A, Gabriele M, Nardi G, Del Monaco G, Baldini K, Tomberli A, Tomberli B, Marchionni N, Di Mario C, Olivotto I, Cappelli F. Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis. Mayo Clin Proc. 2021 Aug;96(8):2185-2191. doi: 10.1016/j.mayocp.2021.04.021. PMID: 34353472.
93. Bandera F, Martone R, Chacko L, Ganesananthan S, Gilbertson JA, Ponticos M, Lane T, Martinez-Naharro A, Whelan C, Quarta C, Rowczenio D, Patel R, Razvi Y, Lachmann H, Wechelakar A, Brown J, Knight D, Moon J, Petrie A, Cappelli F, Guazzi M, Potena L, Rapezzi C, Leone O, Hawkins PN, Gillmore JD, Fontana M. Clinical Importance of  left Atrial Infiltration in Cardiac Transthyretin Amyloidosis. JACC Cardiovasc Imaging. 2021 Aug 11:S1936-878X(21)00512-X. doi: 10.1016/j.jcmg.2021.06.022. Epub ahead of print. PMID: 34419399.
94. Merlo M, Porcari A, Pagura L, Cameli M, Vergaro G, Musumeci B, Biagini E, Canepa M, Crotti L, Imazio M, Forleo C, Cappelli F, Favale S, Di Bella G, Dore F, Lombardi CM, Pavasini R, Rella V, Palmiero G, Caiazza M, Albanese M, Guaricci AI, Branzi G, Caponetti AG, Saturi G, La Malfa G, Merlo AC, Andreis A, Bruno F, Longo F, Sfriso E, Di Ienno L, De Carli G, Giacomin E, Spini V, Milidoni A, Limongelli G, Autore C, Olivotto I, Badano L, Parati G, Perlini S, Metra M, Emdin M, Rapezzi C, Sinagra G. A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study. Eur J Prev Cardiol. 2021 Sep 9:zwab127. doi: 10.1093/eurjpc/zwab127. Epub ahead of print. PMID: 34499711.
95. Tassetti L, Girolami F, Fumagalli C, Argirò A, Ricciardi G, Checchi L, Zocchi C, Berteotti M, Tomberli B, Gabrielli E, Favilli S, Pieroni M, Cappelli F, Tanini I, Pieragnoli P, Marchionni N, Olivotto I. Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing. Circ Arrhythm Electrophysiol. 2021 Dec;14(12):e010562. doi: 10.1161/CIRCEP.121.010562. Epub 2021 Nov 24. PMID: 34814702.
96. Argirò A, Rosenblum H, Griffin J, Batra J, Cappelli F, Burkhoff D, Maurer M, Olivotto I. Sex related differences in exercise performance in patients with hypertrophic cardiomyopathy: Hemodynamic insights through non-invasive pressure volume analysis. Int J Cardiol. 2021 Dec 28:S0167-5273(21)02048-9. doi: 10.1016/j.ijcard.2021.12.045. Epub ahead of print. PMID: 34968627.
97. Batra J, Rosenblum H, Cappelli F, Zampieri M, Olivotto I, Griffin JM, Saith SE, Teruya S, De Los Santos J, Argiro A, Burkhoff D, Perfetto F, Maurer MS. Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis. J Card Fail. 2021 Dec 30:S1071-9164(21)00527-3. doi: 10.1016/j.cardfail.2021.12.016. Epub ahead of print. PMID: 34974181.
98. Zampieri M, Argirò A, Allinovi M, Tassetti L, Zocchi C, Gabriele M, Andrei V, Fumagalli C, Di Mario C, Tomberli A, Olivotto I, Perfetto F, Cappelli F. Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis. Int J Cardiol. 2022 Jan 4:S0167-5273(21)02051-9. doi: 10.1016/j.ijcard.2021.12.048. Epub ahead of print. PMID: 34990715.
99. Zampieri M, Argirò A, Allinovi M, Perfetto F, Cappelli F. SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series. Intern Emerg Med. 2022 Feb 8. doi: 10.1007/s11739-022-02944-8.
100. Tassetti L, Fumagalli C, Argirò A, Zampieri M, Gori M, Verrillo F, Zocchi C, Cappelli F, Olivotto I. Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease. J Cardiovasc Electrophysiol. 2022 Feb 9. doi: 10.1111/jce.15409.
101. Perfetto F, Zampieri M, Fumagalli C, Allinovi M, Cappelli F. Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist. Intern Emerg Med. 2022 Mar 24. doi: 10.1007/s11739-022-02958-2.
102. Merlo M, Pagura L, Porcari A, Cameli M, Vergaro G, Musumeci B, Biagini E, Canepa M, Crotti L, Imazio M, Forleo C, Cappelli F, Perfetto F, Favale S, Di Bella G, Dore F, Girardi F, Tomasoni D, Pavasini R, Rella V, Palmiero G, Caiazza M, Carella MC, Igoren Guaricci A, Branzi G, Caponetti AG, Saturi G, La Malfa G, Merlo AC, Andreis A, Bruno F, Longo F, Rossi M, Varrà GG, Saro R, Di Ienno L, De Carli G, Giacomin E, Arzilli C, Limongelli G, Autore C, Olivotto I, Badano L, Parati G, Perlini S, Metra M, Michele E, Rapezzi C, Sinagra G. Unmasking the Prevalence of Amyloid Cardiomyopathy in the Real World: Results from Phase 2 of AC-TIVE Study, an Italian Nationwide Survey. Eur J Heart Fail. 2022 Apr 13. doi: 10.1002/ejhf.2504.
103. Argiro' A, Cappelli F, Di Mario C. Aortic Stenosis and Cardiac Amyloidosis: PARTNERs in Crime? Cardiovasc Revasc Med. 2022 Oct;43:26-27. doi: 10.1016/j.carrev.2022.07.011. Epub 2022 Jul 25. PMID: 35941068.
104. Innocenti S, Bacchi B, Allinovi M, Perfetto F, Antonioli E, Marchionni N, Di Mario C, Caroti L, Cappelli F, Stefàno P. A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis. BMC Nephrol. 2022 Nov 17;23(1):370. doi: 10.1186/s12882-022-02984-4. PMID: 36397026; PMCID: PMC9673363.
105. Silverii MV, Argirò A, Baldasseroni S, Fumagalli C, Zampieri M, Guerrieri L, Bartolini S, Mazzoni C, Burgisser C, Tomberli A, Di Mario C, Marchionni N, Olivotto I, Perfetto F, Fattirolli F, Cappelli F. Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis. Intern Emerg Med. 2022 Nov 18. doi: 10.1007/s11739-022-03125-3. Epub ahead of print. PMID: 36396841.
106. Mazzarotto F, Argirò A, Zampieri M, Magri C, Giotti I, Boschi B, Frusconi S, Gennarelli M, Buxbaum J, Polimanti R, Olivotto I, Perfetto F, Cappelli F. Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy. Eur J Hum Genet. 2022 Nov 15. doi: 10.1038/s41431-022-01235-2. Epub ahead of print. PMID: 36380086.
107. Argirò A, Del Franco A, Mazzoni C, Allinovi M, Tomberli A, Tarquini R, Di Mario C, Perfetto F, Cappelli F, Zampieri M. Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not. Biomedicines. 2022 Nov 10;10(11):2888. doi: 10.3390/biomedicines10112888. PMID: 36359408; PMCID: PMC9687719.
108. Allinovi M, Bergesio F, Cappelli F, Chiappini MG, Santostefano M, Argirò A, Catalucci T, Parise A, Zampieri M, Perfetto F. Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease? Am J Nephrol. 2022 Nov 7:1-4. doi: 10.1159/000526955. Epub ahead of print. PMID: 36349760.
109. Argirò A, Zampieri M, Dei L, Ferrantini C, Marchi A, Tomberli A, Baldini K, Cappelli F, Favilli S, Passantino S, Zocchi C, Tassetti L, Gabriele M, Maurizi N, Marchionni N, Coppini R, Olivotto I. Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center. Int J Cardiol. 2022 Oct 10:S0167-5273(22)01523-6. doi: 10.1016/j.ijcard.2022.10.014. Epub ahead of print. PMID: 36228766.
110. Cipriani A, De Michieli L, Porcari A, Licchelli L, Sinigiani G, Tini G, Zampieri M, Sessarego E, Argirò A, Fumagalli C, De Gaspari M, Licordari R, Russo D, Di Bella G, Perfetto F, Autore C, Musumeci B, Canepa M, Merlo M, Sinagra G, Gregori D, Iliceto S, Perazzolo Marra M, Cappelli F, Rapezzi C. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value. JACC CardioOncol. 2022 Sep 7;4(4):458-470. doi: 10.1016/j.jaccao.2022.08.007. PMID: 36444225; PMCID: PMC9700257.
111. Argiro' A, Zampieri M, Mazzoni C, Catalucci T, Biondo B, Tomberli A, Gabriele M, Di Mario C, Perfetto F, Cappelli F. Red flags for the diagnosis of cardiac amyloidosis: simple suggestions to raise suspicion and achieve earlier diagnosis. J Cardiovasc Med (Hagerstown). 2022 Aug 1;23(8):493-504. doi: 10.2459/JCM.0000000000001337. PMID: 35904994.
112. Gorini F, Santoro M, Pierini A, Mezzasalma L, Baldacci S, Bargagli E, Boncristiano A, Brunetto MR, Cameli P, Cappelli F, Castaman G, Coco B, Donati MA, Guerrini R, Linari S, Murro V, Olivotto I, Parronchi P, Pochiero F, Rossi O, Scappini B, Sodi A, Vannucchi AM, Coi A. Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study. Front Pharmacol. 2022 May 16;13:869842. doi: 10.3389/fphar.2022.869842. PMID: 35652051; PMCID: PMC9148958.
113. Di Bella G, Cappelli F, Licordari R, Piaggi P, Campisi M, Bellavia D, Minutoli F, Gentile L, Russo M, de Gregorio C, Perfetto F, Mazzeo A, Falletta C, Clemenza F, Vita G, Carerj S, Aquaro GD. Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis. Amyloid. 2022 Sep;29(3):197-204. doi: 10.1080/13506129.2022.2064739. Epub 2022 Apr 23. PMID: 35465808.
114. Cappelli F, Cipriani A, Russo D, Tini G, Zampieri M, Zocchi C, Sinigiani G,Tassetti L, Licchelli L, Perfetto F, Autore C, Musumeci MB. Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis. Amyloid. 2022 Sep;29(3):211-212. doi: 10.1080/13506129.2022.2060073. Epub 2022 Apr 22. PMID: 35451897.
115. Aguiar Rosa S, Thomas B, Pieroni M, Maurizi N, Zampieri M, Cappelli F, Marchi A, Pradella S, Cardim N, Bogaert J, Olivotto I. Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama. Int J Cardiovasc Imaging. 2022 Dec 21. doi: 10.1007/s10554-022-02774-x. Epub ahead of print. PMID: 36543912.
116. Perfetto F, Zampieri M, Bandini G, Fedi R, Tarquini R, Santi R, Novelli L, Allinovi M, Argirò A, Cappelli F. Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease. Biomedicines. 2022 Dec 12;10(12):3226. doi: 10.3390/biomedicines10123226. PMID: 36551982; PMCID: PMC9775219.
117. Porcari A, Rossi M, Cappelli F, Canepa M, Musumeci B, Cipriani A, Tini G, Barbati G, Varrà GG, Morelli C, Fumagalli C, Zampieri M, Argirò A, Vianello PF, Sessarego E, Russo D, Sinigiani G, De Michieli L, Di Bella G, Autore C, Perfetto F, Rapezzi C, Sinagra G, Merlo M. (2022). Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis. EUROPEAN JOURNAL OF HEART FAILURE, vol. 24, p. 1227-1236, ISSN: 1388-9842, doi: 10.1002/ejhf.2533
118. Argiro' A., Cappelli F., Di Mario C. (2022). Aortic Stenosis and Cardiac Amyloidosis: PARTNERs in Crime?. CARDIOVASCULAR REVASCULARIZATION MEDICINE, vol. 43, p. 26-27, ISSN: 1553-8389, doi: 10.1016/j.carrev.2022.07.011
119. Canepa M., Cappelli F., Limongelli G., Luigetti M., Manganelli F., Mazzeo A., Pareyson D., Perlini S., Obici L. (2022). The proper management of the patient with hereditary transthyretin amyloidosis with mixed phenotype: recommendations from a group of Italian experts. DRUGS IN CONTEXT, vol. 11, p. 1-11, ISSN: 1740-4398, doi: 10.7573/dic.2022-3-7
120. Zampieri M, Salvi S, Fumagalli C, Argirò A, Zocchi C, Del Franco A, Iannaccone G, Giovani S, Ferrantini C, Palinkas ED, Cappelli F, Olivotto I. Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation. Int J Cardiol. 2023 Jan 5:S0167-5273(22)01981-7. doi: 10.1016/j.ijcard.2022.12.056. Epub ahead of print. PMID: 36621577.
121. Ponti L, Smorti M, Pozza F, Argirò A, Zampieri M, Mazzoni C, Gabriele M, Mario CD, Olivotto I, Perfetto F, Cappelli F. Anxious/Depressive Symptoms Alter the Subjective Perception of Heart Failure Severity in Transthyretin Cardiac Amyloidosis. Am J Cardiol. 2023 Jan 21;192:1-6. doi: 10.1016/j.amjcard.2023.01.007.
122. Sinagra G, Emdin M, Merlo M, Vergaro G, Aimo A, Biagini E, Imazio M, Porcari A, Limongelli G, Cipriani A, Canepa M, Musumeci B, Cameli M, Crotti L, Di Bella G, Di Lenarda A, Cappelli F, Chimenti C, Obici L, Iacoviello M, Perlini S, Pieroni M, Metra M, Oliva F, Perrone Filardi P, Colivicchi F, Indolfi C. Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca [Rationale and significance of the Italian Network for Cardiac Amyloidosis]. G Ital Cardiol (Rome). 2023 Feb;24(2):93-98. Italian. doi: 10.1714/3963.39416.
123. Smorti M, Ponti L, Soffio F, Argirò A, Perfetto F, Zampieri M, Mazzoni C, Tomberli A, Allinovi M, Di Mario C, Olivotto I, Cappelli F. Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis. Front Psychol. 2023 Jan 18;13:1066224. doi: 10.3389/fpsyg.2022.1066224.
124. Tini G, Milani P, Zampieri M, Caponetti AG, Fabris F, Foli A, Argirò A, Mazzoni C, Gagliardi C, Longhi S, Saturi G, Vergaro G, Aimo A, Russo D, Varrà GG, Serenelli M, Fabbri G, De Michieli L, Palmiero G, Ciliberti G, Carigi S, Sessarego E, Mandoli GE, Ricci Lucchi G, Rella V, Monti E, Gardini E, Bartolotti M, Crotti L, Merli E, Mussinelli R, Vianello PF, Cameli M, Marzo F, Guerra F, Limongelli G, Cipriani A, Perlini S, Obici L, Perfetto F, Autore C, Porto I, Rapezzi C, Sinagra G, Merlo M, Musumeci B, Emdin M, Biagini E, Cappelli F, Palladini G, Canepa M. Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study. Eur J Heart Fail. 2023 Mar 12. doi: 10.1002/ejhf.2823. Epub ahead of print. PMID: 36907828.
125. Rauf MU, Hawkins PN, Cappelli F, Perfetto F, Zampieri M, Argiro A, Petrie A, Law S, Porcari A, Razvi Y, Bomsztyk J, Ravichandran S, Ioannou A, Patel R, Starr N, Hutt DF, Mahmood S, Wisniowski B, Martinez-Naharro A, Venneri L, Whelan C, Roczenio D, Gilbertson J, Lachmann HJ, Wechalekar AD, Rapezzi C, Serenelli M, Massa P, Caponetti AG, Ponziani A, Accietto A, Giovannetti A, Saturi G, Sguazzotti M, Gagliardi C, Biagini E, Longhi S, Fontana M, Gillmore JD. Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis. Eur Heart J. 2023 Mar 22:ehad139. doi: 10.1093/eurheartj/ehad139. Epub ahead of print. PMID: 36946431.
126. Cappelli F, Del Franco A, Vergaro G, Mazzoni C, Argirò A, Pieroni M, Giacomin E, Poli S, Allinovi M, Olivotto I, Pieroni F, Scaletti C, Emdin M, Perfetto F. Prevalence of transthyretin-related amyloidosis in Tuscany: Data from the regional population-based registry. Int J Cardiol. 2023 Mar 31:S0167-5273(23)00475-8. doi: 10.1016/j.ijcard.2023.03.063. Epub ahead of print. PMID: 37004943.
127. Fumagalli C, Bonanni F, Beltrami M, Ruggieri R, Zocchi C, Tassetti L, Maurizi N, Berteotti M, Zampieri M, Argirò A, Lovero F, Tomberli A, di Bari M, Marchionni N, Pieragnoli P, Ricciardi G, Checchi L, Cappelli F, Fumagalli S, Olivotto I. Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring. Int J Cardiol. 2023 Apr 13:S0167-5273(23)00523-5. doi: 10.1016/j.ijcard.2023.04.008. Epub ahead of print. PMID: 37061097.
128. Argirò, Alessia, Zampieri, Mattia, Marchi, Alberto, Cappelli, Francesco, Del Franco, Annamaria, Mazzoni, Carlotta, Cecchi, Franco, Olivotto, Iacopo (2023). Stage-specific therapy for hypertrophic cardiomyopathy. EUROPEAN HEART JOURNAL SUPPLEMENTS, vol. 25, p. 155-161, ISSN: 1554-2815, doi: 10.1093/eurheartjsupp/suad042
129. Fumagalli C, Smorti M, Ponti L, Pozza F, Argirò A, Credi G, Di Mario C, Marfella R, Marchionni N, Olivotto I, Perfetto F, Ungar A, Cappelli F. Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis. Aging Clin Exp Res. 2023 May 2. doi: 10.1007/s40520-023-02419-6. Epub ahead of print. PMID: 37129709.
130. Fumagalli C, Zocchi C, Cappelli F, Celata A, Tassetti L, Sasso L, Zampieri M, Argirò A, Marchi A, Targetti M, Berteotti M, Maurizi N, Mori F, Livi P, Baldini K, Tomberli A, Girolami F, Favilli S, Mecacci F, Olivotto I. Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy. Eur J Prev Cardiol. 2023 Aug 2:zwad257. doi: 10.1093/eurjpc/zwad257.
131. Caniato F, Lazzeri C, Bonizzoli M, Mattesini A, Batacchi S, Cappelli F, Di Mario C, Peris A. Urgent coronary angiography in out-of-hospital cardiac arrest: a retrospective single centre investigation. J Cardiovasc Med (Hagerstown). 2023 Sep 1;24(9):637-641. doi: 10.2459/JCM.0000000000001510.
132. Aimo A, Teresi L, Castiglione V, Picerni AL, Niccolai M, Severino S, Agazio A, Carnevale Baraglia A, Obici L, Palladini G, Ponti L, Argirò A, Cappelli F, Perfetto F, Serenelli M, Trimarchi G, Licordari R, Di Bella G, Chubuchna O, Quattrone F, Nuti S, De Rosis S, Passino C, Rapezzi C, Merlini G, Emdin M, Vergaro G. Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study. Amyloid. 2023 Sep 5:1-10. doi: 10.1080/13506129.2023.2254451.
133. Fumagalli C, Zampieri M, Argirò A, Tassetti L, Rossi G, Musumeci B, Tini G, Russo D, Sclafani M, Cipriani A, Sinigiani G, Di Bella G, Licordari R, Canepa M, Vianello PF, Merlo M, Porcari A, Rossi M, Sinagra G, Rapezzi C, Di Mario C, Ungar A, Olivotto I, Perfetto F, Cappelli F. Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis. Int J Cardiol. 2023 Dec 1;392:131346. doi: 10.1016/j.ijcard.2023.131346. Epub 2023 Sep 7.
134. Russo D, Cappelli F, Di Bella G, Tini G, Porcari A, Cipriani A, Canepa M, Merlo M, Licordari R, Vianello PF, Zampieri M, De Michieli L, Scirpa R, Perfetto F, Sinagra G, Autore C, Rapezzi C, Musumeci MB. Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations. Int J Cardiol. 2023 Dec 15;393:131354. doi: 10.1016/j.ijcard.2023.131354.
135. Ponti L, Hsu K, Damy T, Villacorta E, Verheyen N, Keohane D, Wang R, Ines M, Kumar N, Munteanu C, Cappelli F. Burden of untreated transthyretin amyloid cardiomyopathy on patients and their caregivers by disease severity: results from a multicenter, non-interventional, real-world study. Front Cardiovasc Med. 2023 Aug 29;10:1238843. doi: 10.3389/fcvm.2023.1238843.
136. Argirò A, Zampieri M, Marchi A, Del Franco A, Pàlinkàs ED, Biagioni G, Chiti C, Mazzoni C, Fornaro A, Targetti M, Cappelli F, Olivotto I. Approcci terapeutici nella cardiomiopatia ipertrofica: dal controllo dei sintomi alla terapia di precisione [Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy]. G Ital Cardiol (Rome). 2023 Oct;24(10):792-799. Italian. doi: 10.1714/4100.40979. PMID: 37767831.
137. Del Franco A, Iannaccone G, Meucci MC, Lillo R, Cappelli F, Zocchi C, Pieroni M, Graziani F, Olivotto I. Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal. Heart Fail Rev. 2023 Nov 25. doi: 10.1007/s10741-023-10370-x. Epub ahead of print. PMID: 38006470.
138. Argirò A, Silverii MV, Burgisser C, Fattirolli F, Baldasseroni S, di Mario C, Zampieri M, Biagioni G, Mazzoni C, Chiti C, Allinovi M, Ungar A, Perfetto F, Cappelli F. Serial Changes in Cardiopulmonary Exercise Testing Parameters in Untreated Patients With Transthyretin Cardiac Amyloidosis. Can J Cardiol. 2023 Oct 2:S0828-282X(23)01745-2. doi: 10.1016/j.cjca.2023.09.028. Epub ahead of print. PMID: 37793568.
139. Del Franco A, Biagioni G, Mazzoni C, Cappelli F. Amyloidosis in spinal stenosis: How, when and whether cardiac screening has a clinical impact. Int J Cardiol. 2024 Jan 15;395:131413. doi: 10.1016/j.ijcard.2023.131413. Epub 2023 Oct 5. PMID: 37802296.

Francesco Cappelli, is a Cardiologist, PhD in Pathophysiology of ageing  and Assistant professor of cardiovascular medicine at the University of Florence. Head of the cardiac clinic in the Tuscan Regional Referral center for the treatment of amyloidosis at Careggi University Hospital, Florence Italy.

His research interests focus on infiltrative cardiac disease especially Amyloidosis .

Francesco Cappelli

Telephone Number: +39 3382504484

E-mail:f.cappelli@unifi.it

Date of birth:13 July 1979

Current employment status 

1 November 2021 till now

Assistant Professor in Cardiology at University of Florence. Cardiologist at Azienda Ospedaliero Universitaria Careggi, in the Intensive Cardiac Care Unit. SOD Interventistica Cardiologica Strutturale, Largo Brambilla 3, 50134 Firenze

 Jannuary 2010 till now

Referral cardiologist of Tuscan regional amyloid referral centre Azienda Ospedialiera Universitaria Careggi University of Florence: diagnosis of cardiac amyloidosis, therapy management, networking with other AOUC amyloidosis professionals and with other referral center mainly CNR (Pisa), Sant’Orsola (Bologna), Ospedale San Matteo (Pavia), Ospedale Sant’Andrea Sapienza (Rome), National Amyloid Center (London).

Education

Medical school: University of Florence, 1998-2004, full mark cum laude

Cardiology residency: University of Florence, 2005-2008, full mark cum laude

Board certification: Italian board of cardiology, 2008

Phd in Clinical Science    University of Florence 2019-2021

Training and previous work experience

July-August 2003

Training in cardiology at Beth Israel Deaconess Medical Center Harvard Medical School of medicine Boston MA, USA.

June 2004- December 2009

Post- graduate training in the Echocardiography Lab held by Dott.ssa M.C. Porciani Azienda Ospedialiera Universitaria Careggi University of Florence

Jannuary2007-December 2009

Post- graduate training in the Tuscan regional amyloid referral centre Azienda Ospedialiera Universitaria Careggi University of Florence held by Dott. Franco Bergesio and Dott. Federico Perfetto

October 2008-November 2009

Winner of a 1 year Research Grant  of “Società Italiana per l’Amiloidosi” (Italian Amyloid Society) with a Project “Utility of Tissue Doppler Imaging for early diagnosis of cardiac involvement in systemic amyloidosis”

Jannuary 2010 till 30 0ctober 2021

Cardiologist at Azienda  Ospedaliero Universitaria Careggi, in the Intensive Cardiac Care Unit. SOD Interventistica Cardiologica Strutturale, Largo Brambilla 3, 50134 

Pubblication in peer review journals

Total citation = 2,655 (Scopus)

Hirsch  index (H-index)= 27   (Scopus)

1. Macioce, R., Cappelli. F., Demarchi, G., Lilli, A., Ricciardi, G., Pieragnoli, P., Colella, A., Michelucci, A., Porciani, M. C., Padeletti, L. Resynchronization of mitral valve annular segments reduces functional mitral regurgitation in cardiac resynchronization therapy. Minerva Cardioangiol. 2005 Aug;53(4):329-33
2. M.C. Porciani, R. Macioce, G. Demarchi, M. Chiostri, N. Musilli, F. Cappelli, A. Lilli, G. Ricciardi  L. Padeletti  Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure. Eur J Echocardiogr2006 Jan;7(1):31-9
3. Porciani MC, Lilli A, Macioce R, Cappelli F, Demarchi G, Pappone A, Ricciardi G, Padeletti L.Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy.Eur Heart J. 2006 Aug;27(15):1818-23.
4. Porciani MC, Dondina C, Macioce R, Demarchi G, Cappelli F, Lilli A, Pappone A, Ricciardi G, Colombo PC, Padeletti M, Jelic S, Padeletti L.Temporal variation in optimal atrioventricular and interventricular delay during cardiac resynchronization therapy. J Card Fail. 2006 Dec;12(9):715-9.
5. Cappelli F, Ermini FR, Del Pace S, Micheli S, Gensini GF. Favourable outcome of  streptococcus agalactiae prosthetic valve endocarditis after conservative treatment. Int J Cardiol. 2007 Jan 8;114(2):E73-4.
6. Porciani MC, Rao CM, Mochi M, Cappelli F, Bongiorno G, Perini AP, Ricciardi G, Hastroudi L, Silvestri P,Barold SS, Padeletti L. A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. Pacing Clin Electrophysiol 2008 Jan(1):56-63.
7. Cappelli F, Lazzeri C, Gensini GF, Valente S.Cannabis: a trigger for acute myocardial infarction? A case report J Cardiovasc Med 2008 9:725-728
8. Berni A, Cappelli F, Bitossi L, Cecioni I, Cappelli B, Toncelli L, Galanti G, Poggesi L. Non-invasive tissue Doppler imaging pulmonary capillary wedge pressure measurement improves NT-proBNP prognostic value in heart failure. Acta Cardiol.2009 Apr;64(2):213-8.
9. Porciani, M. C., Lilli, A., Perfetto, F., Cappelli, F., Rao, C. M., Del Pace, S., Ciaccheri, M., Castelli, G., Tarquini, R., Romagnani, L., Pastorini, T., Padelletti, L., Bergesio, F. Tissue Doppler and Strain Imaging: a new tool for early detection of cardiac amyloidosis? Amyloid, June 2009 Vol 16 (2) 63-70
10. Cappelli F, Valente S, Gensini GF. Is it time to consider cannabis smoking a cardiovascular risk factor? J Cardiovasc Med (Hagerstown). 2009 Oct;10(10):745-6.
11. Porciani CM, Lilli A, Cappelli F, Pappone A, Perini AP, Pieragnoli P, Ricciardi G, Rao CM, Prinzen FW, Michelucci A, Padeletti L.Echo/Doppler-derived  time intervals are able to predict left ventricular reverse remodeling after cardiac resynchronization therapy. J Cardiovasc Med (Hagerstown). 2009 Oct 16.
12. Padeletti L, Valleggi A, Vergaro G, Lucà F, Rao CM, Perrotta L, Cappelli F, L'Abbate A, Passino C, Emdin M. Concordant versus discordant left bundle branch block in heart failure patients: novel clinical value of an old electrocardiographic diagnosis. J Card Fail. 2010 Apr;16(4):320-6. doi: 10.1016/j.cardfail.2009.12.005. Epub 2010 Jan 18. PMID: 20350699.
13. Cappelli F, Toncelli L, Cappelli B, De Luca A, Stefani L, Maffulli N, Galanti G. Adaptative or maladaptative hypertrophy, different spatial distribution of myocardial contraction. Clin Physiol Funct Imaging. 2010 Jan;30(1):6-12. doi: 10.1111/j.1475-097X.2009.00896.x
14. Porciani MC, Cappelli F, Perrotta L, Chiostri M, Rao CM, Pieragnoli P, Ricciardi G, Michelucci A, Jelic S, Padeletti L. Has mechanical dyssynchrony still a role in predicting cardiac resynchronization therapy response? Echocardiography. 2010 Aug;27(7):831-8. doi: 10.1111/j.1540-8175.2009.01133.x
15. Cappelli F, Vignini S, Baldereschi GJ. ALN inferior vena cava filter upside down rotation with chest caval migration in an asymptomatic patient. J InvasiveCardiol. 2010 Aug;22(8):E153-5
16. Cappelli F, Cristina Porciani M, Ricceri I, Perrotta L, Ricciardi G,Pieragnoli P, Paladini G, Michelucci A, Padeletti L. Tricuspid annular planesystolic excursion evaluation improves selection of cardiac resynchronizationtherapy patients. Clin Cardiol. 2010 Sep;33(9):578-82. doi: 10.1002/clc.20806
17. Porciani MC, Cappelli F, Perfetto F, Ciaccheri M, Castelli G, Ricceri I,Chiostri M, Franco B, Padeletti L. Rotational mechanics of the left ventricle in AL amyloidosis. Echocardiography. 2010 Oct;27(9):1061-8. doi: 10.1111/j.1540-8175.2010.01199.x.
18. Cappelli F, Porciani MC, Bergesio F, Perfetto F, De Antoniis F, Cania A, Tronconi F, Ricceri I, Padeletti L. Characteristics of left ventricular rotational mechanics in patients with systemic amyloidosis, systemic hypertension and normal left ventricular mass. Clin Physiol Funct Imaging. 2011Mar;31(2):159-65. doi: 10.1111/j.1475-097X.2010.00987.x.
19. Cappelli F, Del Bene MR, Barletta G. Three-dimensional transesophageal evaluation of prosthetic perivalvular leak. G Ital Cardiol (Rome). 2010Nov;11(11):860
20. Perfetto F, Cappelli F, Bergesio F. Asymptomatic homozygous gene carrier in afamily with Ile68Leu ATTR amyloidosis: a new endemic region in northern Tuscany? J Cardiovasc Med (Hagerstown). 2011 Jun;12(6):450-1. doi:10.2459/JCM.0b013e3283464e12.
21. Cappelli F, Del Bene MR, Santoro G, Meucci F, Attanà P, Barletta G. The challenge of integrated echocardiographic approach in percutaneous closure ofparavalvular leak. Echocardiography. 2011 Sep;28(8):E168-71. doi:10.1111/j.1540-8175.2011.01444.x.
22. Perfetto F, Porciani MC, Cappelli F. Rotational mechanics of the leftventricle in amyloid light chain amyloidosis. Am J Cardiol. 2011 Dec1;108(11):1686-7. doi: 10.1016/j.amjcard.2011.08.018.
23. Del Bene MR, Cappelli F, Rega L, Venditti F, Barletta G. Characterization of  Löeffler eosinophilic myocarditis by means of real time three-dimensionalcontrast-enhanced echocardiography. Echocardiography. 2012 Mar;29(3):E62-6. doi: 10.1111/j.1540-8175.2011.01570.x.
24. Cappelli F, Porciani MC, Bergesio F, Perlini S, Attanà P, Moggi Pignone A, Salinaro F, Musca F, Padeletti L, Perfetto F. Right ventricular function in ALamyloidosis: characteristics and prognostic implication. Eur Heart J CardiovascImaging. 2012 May;13(5):416-22. doi: 10.1093/ejechocard/jer289.
25. Cappelli F, Favilli S, Ricciardi G, Pieragnoli P, Padeletti L. Atrial standstill disease progression documented after 13 years follow-up. Intern Emerg Med. 2012 May;7 Suppl 1:S7-8. doi: 10.1007/s11739-011-0519-5.
26. Smorti M, Cappelli F, Bergesio F, Perfetto F. Anxiety and depression among ALamyloidosis patients: the role of cardiac symptoms. Amyloid. 2012Sep;19(3):123-8. doi: 10.3109/13506129.2012.687420.
27. Rapezzi C, Quarta CC, Obici L, Perfetto F, Longhi S, Salvi F, Biagini E, Lorenzini M, Grigioni F, Leone O, Cappelli F, Palladini G, Rimessi P, Ferlini A,  Arpesella G, Pinna AD, Merlini G, Perlini S. Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. Eur Heart J. 2013 Feb;34(7):520-8 doi: 10.1093/eurheartj/ehs123.
28. Perfetto  F, Cappelli F, Bergesio F, Ciuti G, Porciani MC, Padeletti L, Moggi  Pignone A. Cardiac amyloidosis: the heart of the matter. Intern Emerg Med. 2013Apr;8(3):191-203. doi: 10.1007/s11739-011-0647-y
29. Cappelli F, Perlini S, Attanà P, Ciuti G, Salinaro F, Perfetto F. As we cannot afford to renounce to new generation echocardiography in systemic amyloidosis. Amyloid. 2013 Sep;20(3):195-6. doi: 10.3109/13506129.2013.808993.
30. Perlini S, Salinaro F, Cappelli F, Perfetto F, Bergesio F, Alogna A, Mussinelli R, Boldrini M, Raimondi A, Musca F, Palladini G, Merlini G. Prognostic value of fragmented QRS in cardiac AL amyloidosis. Int J Cardiol. 2013 Sep 1;167(5):2156-61. doi: 10.1016/j.ijcard.2012.05.097.
31. Cappelli F, Padeletti L, Acquafresca M, Pignone AM, Perfetto F. Repeated systemic thromboembolism in a patient with severe cardiac AL amyloidosis without  evidence of atrial fibrillation. Intern Emerg Med. 2014 Mar;9(2):243-5. doi: 10.1007/s11739-013-0960-8.
32. Smorti M, Cappelli F, Guarnieri S, Bergesio F, Perfetto F. Depression and cardiac symptoms among AL amyloidosis patients: the mediating role of coping strategies. Psychol Health Med. 2014;19(3):263-72. doi: 10.1080/13548506.2013.802357.
33. Perfetto F, Bergesio F, Emdin M, Cappelli F. Troponins in cardiac amyloidosis: multipurpose markers. Nat Rev Cardiol. 2014 Mar;11(3):179. doi: 10.1038/nrcardio.2013.129-c1.
34. Perlini S, Salinaro F, Musca F, Mussinelli R, Boldrini M, Raimondi A, Milani P, Foli A, Cappelli F, Perfetto F, Palladini G, Rapezzi C, Merlini G. Prognostic  value of depressed midwall systolic function in cardiac light-chain amyloidosis.  J Hypertens. 2014 May;32(5):1121-31; discussion 1131. doi: 10.1097/HJH.0000000000000120.
35. Cappelli F, Baldasseroni S, Bergesio F, Padeletti L, Attanà P, Pignone AM, Grifoni E, Ciuti G, Fabbri A, Tarantini F, Marchionni N, Gensini GF, Perfetto F.  Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. Amyloid. 2014 Jun;21(2):97-102. doi: 10.3109/13506129.2014.884971.
36. Aquaro GD, Pugliese NR, Perfetto F, Cappelli F, Barison A, Masci PG, Passino C, Emdin M. Myocardial signal intensity decay after gadolinium injection: a fast  and effective method for the diagnosis of cardiac amyloidosis. Int J Cardiovasc Imaging. 2014 Aug;30(6):1105-15. doi: 10.1007/s10554-014-0436-6.
37. Smorti A, Cappelli F, Zarantonello R, Tani F, Gensini GF. Medical error and systems of signaling: conceptual and linguistic definition. Intern Emerg Med. 2014 Jul 18. PubMed PMID: 25034521.
38. Attanà P, Paoletti Perini A, Votta CD, Cappelli F, Pieragnoli P, Ricciardi G,  Nesti M, Giomi A, Sacchi S, Chiostri M, Padeletti L. QRS duration in left bundle branch block does not affect left ventricular twisting in chronic systolic heart failure. Clin Physiol Funct Imaging. 2014 Jul 31. doi: 10.1111/cpf.12181. [Epubahead of print] PubMed PMID: 25077412.
39. Barison A, Aquaro GD, Pugliese NR, Cappelli F, Chiappino S, Vergaro G, Mirizzi G, Todiere G, Passino C, Masci PG, Perfetto F, Emdin M. Measurement of myocardialamyloid deposition in systemic amyloidosis: insights from cardiovascular magneticresonance imaging. J Intern Med. 2014 Oct 24. doi: 10.1111/joim.12324. [Epubahead of print] PubMed PMID: 25346163.
40. Smorti M, Guarnieri S, Bergesio F, Perfetto F, Cappelli F. Anxiety anddepression among amyloid light-chain cardiac amyloidosis patients: The role oflife satisfaction. Eur J Cardiovasc Nurs. 2015 Jan 19. pii: 1474515114566737.[Epub ahead of print] PubMed PMID: 25601945.
41. Cappelli F, Baldasseroni S, Bergesio F, Perlini S, Salinaro F, Padeletti L,Attanà P, Paoletti Perini A, Moggi Pignone A, Grifoni E, Fabbri A, Marchionni N, Gensini GF, Perfetto F. chocardiographic and Biohumoral Characteristics in Patients With AL and TTR Amyloidosis at Diagnosis. Clin Cardiol. 2015Feb;38(2):69-75. doi: 10.1002/clc.22353.. PubMed PMID: 25645201.
42. Perfetto F, Frusconi, S, Bergesio F,Giforni, E, Fabbri, A, Giuliani, C, Falconi, S, Bonifacio, S , Cappelli, F (2015). The Val142Ile transthyretin cardiac amyloidosis: more than an Afro-American pathogenic variant. JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERPECTIVES, vol. 5, p. 26931, ISSN: 2000-9666
43. Neglia D, Rovai D, Caselli C, Pietila M, Teresinska A, Aguadé-Bruix S, Pizzi MN, Todiere G, Gimelli A, Schroeder S, Drosch T, Poddighe R, Casolo G, Anagnostopoulos C, Pugliese F, Rouzet F, Le Guludec D, Cappelli F, Valente S,Gensini GF, Zawaideh C, Capitanio S,Sambuceti G, Marsico F, Perrone Filardi P,Fernández-Golfín C, Rincón LM, Graner FP, de Graaf MA, Fiechter M, Stehli J,Gaemperli O, Reyes E, Nkomo S, Mäki M, Lorenzoni V, Turchetti G, Carpeggiani C,Marinelli M, Puzzuoli S, Mangione M, Marcheschi P, Mariani F, Giannessi D, Nekolla S, Lombardi M, Sicari R, Scholte AJ, Zamorano JL, Kaufmann PA, Underwood  SR, Knuuti J; EVINCI Study Investigators. Detection of significant coronaryartery disease by noninvasive anatomical and functional imaging. Circ Cardiovasc Imaging. 2015 Mar;8(3). pii: e002179. doi: 10.1161/CIRCIMAGING.114.002179. PubMedPMID: 25711274.
44. Cappelli F, Frusconi S, Bergesio F, Grifoni E, Fabbri A, Giuliani C, Falconi S, Bonifacio S, Perfetto F. The Val142Ile transthyretin cardiac amyloidosis: not only an afro American pathogenic variant? A single center Italian experience. Journal of Cardiovascular Medicine 2016 Feb;17(2):122-5.44)
45. Perfetto F, Bergesio F, Grifoni E, Fabbri A, Ciuti G, Frusconi S, Angelotti P, Spini V, Cappelli F. Different NT-proBNP circulating levels for different types of cardiac amyloidosis. J Cardiovasc Med (Hagerstown). 2016 Jan 12.. [Epub ahead of print]
46. : Liga R, Vontobel J, Rovai D, Marinelli M, Caselli C, Pietila M, Teresinska A, Aguadé-Bruix S, Pizzi MN, Todiere G, Gimelli A, Chiappino D, Marraccini P, Schroeder S, Drosch T, Poddighe R, Casolo G, Anagnostopoulos C, Pugliese F,Rouzet F, Le Guludec D, Cappelli F, Valente S, Gensini GF, Zawaideh C, Capitanio S, Sambuceti G, Marsico F, Filardi PP, Fernández-Golfín C, RincÃn LM, Graner FP, de Graaf MA, Stehli J, Reyes E, Nkomo S, MÃki M, Lorenzoni V, Turchetti G,Carpeggiani C, Puzzuoli S, Mangione M, Marcheschi P, Giannessi D, Nekolla S,Lombardi M, Sicari R, Scholte AJ, Zamorano JL, Underwood SR, Knuuti J, KaufmannPA, Neglia D, Gaemperli O; EVINCI Study Investigators. Multicentre multi-devicehybrid imaging study of coronary artery disease: results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of IschaemicHeart Disease (EVINCI) hybrid imaging population. Eur Heart J Cardiovasc Imaging.2016 Mar 18. pii: jew038. [Epub ahead of print] Review. PubMed PMID: 26992419.
47. Cappelli F, Baldasseroni S, Bergesio F, Spini V, Fabbri A, Angelotti P, Grifoni E, Attanà P, Tarantini F, Marchionni N, Moggi Pignone A, Perfetto F. Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system. Intern Emerg Med. 2017 Feb;12(1):23-30. doi: 10.1007/s11739-016-1500-0
48. Scarpino M, Lanzo G, Cappelli F, Moretti M, Misuri G, Voltolini L, Pistolesi M, Amantini A, Grippo A. Cerebral Fat Embolism After Video-Assisted Thoracic Surgery. Ann Thorac Surg. 2016 Nov;102(5):e409-e411. doi: 10.1016/j.athoracsur.2016.04.073.
49. Tomberli B, Cappelli F, Perfetto F, Olivotto I. Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy. JAMA Cardiol. 2017 Jan 1;2(1):94-97. doi: 10.1001/jamacardio.2016.3894.
50. Cappelli F, Gallini C, Di Mario C, Costanzo EN, Vaggelli L, Tutino F, Ciaccio  A, Bartolini S, Angelotti P, Frusconi S, Farsetti S, Vergaro G, Giorgetti A, Marzullo P, Genovesi D, Emdin M, Perfetto F. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis. J  Nucl Cardiol. 2017 May 23. doi: 10.1007/s12350-017-0922-z.
51. Cappelli F, Morini S, Pieragnoli P, Targetti M, Stefàno P, Marchionni N, Olivotto I. Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy: The Need for Disease-Specific Criteria. J Am Coll Cardiol. 2018 Jan 30;71(4):464-466. doi: 10.1016/j.jacc.2017.11.040.
52. Cappelli F, Gallini C, Costanzo EN, Tutino F, Ciaccio A, Vaggelli L, Bartolini S, Morini S, Martone R, Angelotti P, Frusconi S, Di Mario C, Perfetto F. Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon. Int J Cardiol. 2018 Mar 1;254:346-350.
53. Cappelli F, Martone R, Taborchi G, Morini S, Bartolini S, Angelotti P, Farsetti S, Di Mario C, Perfetto F. Epigallocatechin-3-gallate tolerability and impact on survival in a cohort of patients with transthyretin-related cardiac amyloidosis. A single-center retrospective study. Intern Emerg Med. 2018 Jun 7. doi: 10.1007/s11739-018-1887-x.
54. Agostini C, Stolcova M, Bernardo P, Cappelli F, Sori A, Mattesini A, Meucci F, Sorini Dini C, Cianchi G, Peris A, Di Mario C, Valente S. Tips and tricks for using extracorporeal life support devices in the intensive cardiac care unit. G  Ital Cardiol (Rome). 2018 Jun;19(6):14-22. doi: 10.1714/2939.29546.
55. Gagliardi C, Perfetto F, Lorenzini M, Ferlini A, Salvi F, Milandri A, Quarta CC, Taborchi G, Bartolini S, Frusconi S, Martone R, Cinelli MM, Foffi S, Reggiani MLB, Fabbri G, Cataldo P, Cappelli F, Rapezzi C. Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure. Eur J Heart  Fail. 2018 Aug 2. doi: 10.1002/ejhf.1285.
56. Gallini C, Tutino F, Martone R, Ciaccio A, Costanzo EN, Taborchi G, Morini S,  Bartolini S, Farsetti S, Di Mario C, Perfetto F, Cappelli F. Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy. J Nucl Cardiol. 2019 Feb 14. doi: 10.1007/s12350-019-01643-w.
57. Martone R, Marchionni N, Cappelli F. Heart failure with mid-range ejection fraction: Current evidence and uncertainties. Monaldi Arch Chest Dis. 2019 Apr 8;89(1). doi: 0.4081/monaldi.2019.1024. PubMed PMID: 30968665.
58. Lorenzoni V, Bellelli S, Caselli C, Knuuti J, Underwood SR, Neglia D, Turchetti G, Pietila M, Mäki M, Teresinska A, Aguadé-Bruix S, Pizzi MN, Todiere G, Gimelli A, Lombardi M, Puzzuoli S, Mangione M, Marcheschi P, Schroeder S, Drosch T, Poddighe R, Casolo G, Anagnostopoulos C, Pugliese F, Rouzet F, Le Guludec D, Cappelli F, Valente S, Gensini GF, Zawaideh C, Capitanio S, Sambuceti G, Marsico F, Filardi PP, Fernández-Golfín C, Rincón LM, Zamorano JL, Graner FP, Nekolla S, de Graaf MA, Scholte AJHA, Fiechter M, Stehli J, Gaemperli O, Kaufmann PA, Reyes E, Nkomo S, Carpeggiani C, Giannessi D, Mariani F, Marinelli M, Sicari R (2019). Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS, vol. 20, p. 1437-1449, ISSN: 1618-7601, doi: 10.1007/s10198-019-01096-5
59. Cappelli F, Gallini C, Perfetto F. PYP or DPD and HDP for cardiac amyloidosis one for all, all for one. J Nucl Cardiol. 2019 May 1. doi: 10.1007/s12350-019-01728-6. [Epub ahead of print] PubMed PMID: 31044407
60. Canepa M, Tini G, Musumeci B, Cappelli F, Milandri A, Mussinelli R, Autore C,  Perfetto F, Rapezzi C, Perlini S. Real-world versus trial patients with transthyretin amyloid cardiomyopathy. Eur J Heart Fail. 2019 Nov;21(11):1479-1481. doi: 10.1002/ejhf.1563. Epub 2019 Jul 24. PubMed PMID:31339212.
61. Chacko L, Martone R, Cappelli F, Fontana M. Cardiac Amyloidosis: Updates in Imaging. Curr Cardiol Rep. 2019 Aug 2;21(9):108. doi: 10.1007/s11886-019-1180-2.  Review. PubMed PMID: 31375984; PubMed Central PMCID: PMC6677705.
62. Martone R, Perfetto F, Cappelli F. A Man in His 80s With Hypertension, Left Ventricular Hypertrophy, and Enlarged Biceps. JAMA Cardiol. 2019 Oct 16. doi:10.1001/jamacardio.2019.3899. [Epub ahead of print] PubMed PMID: 31617859.
63. Musumeci MB, Cappelli F, Russo D, Tini G, Canepa M, Milandri A, Bonfiglioli R, Di Bella G, My F, Luigetti M, Grandis M, Autore C, Perlini S, Perfetto F, Rapezzi C. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2019 Dec 18. pii: S1936-878X(19)31012-5. doi: 10.1016/j.jcmg.2019.10.015. [Epub ahead of print] PubMed PMID: 31864976.
64. Boldrini M, Cappelli F, Chacko L, Restrepo-Cordoba MA, Lopez-Sainz A, GiannoniA, Aimo A, Baggiano A, Martinez-Naharro A, Whelan C, Quarta C, Passino C,Castiglione V, Chubuchnyi V, Spini V, Taddei C, Vergaro G, Petrie A,Ruiz-Guerrero L, Moñivas V, Mingo-Santos S, Mirelis JG, Dominguez F,Gonzalez-Lopez E, Perlini S, Pontone G, Gillmore J, Hawkins PN, Garcia-Pavia P,Emdin M, Fontana M. Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2019 Dec 18. pii: S1936-878X(19)31007-1. doi: 10.1016/j.jcmg.2019.10.011. [Epub ahead of print]PubMed PMID: 31864973.
65. Cappelli F, Martone R, Gabriele M, Taborchi G, Morini S, Vignini E, Allinovi M, Di Gioia M, Bartolini S, Di Mario C, Perfetto F. Biomarkers and Prediction of  Prognosis in Transthyretin-Related Cardiac Amyloidosis: Direct Comparison of Two Staging Systems. Can J Cardiol. 2020 Mar;36(3):424-431. doi: 10.1016/j.cjca.2019.12.020. Epub 2019 Dec 30. PubMed PMID: 32145869.
66. Chacko L, Martone R, Bandera F, Lane T, Martinez-Naharro A, Boldrini M, Rezk T, Whelan C, Quarta C, Rowczenio D, Gilbertson JA, Wongwarawipat T, Lachmann H, Wechalekar A, Sachchithanantham S, Mahmood S, Marcucci R, Knight D, Hutt D, Moon J, Petrie A, Cappelli F, Guazzi M, Hawkins PN, Gillmore JD, Fontana M. Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.Eur Heart J. 2020 Jan 17. pii: ehz905. doi: 10.1093/eurheartj/ehz905. [Epub ahead of print] PubMed PMID: 31950987.
67. Cappelli F, Vignini E, Martone R, Perlini S, Mussinelli R, Sabena A, Morini S, Gabriele M, Taborchi G, Bartolini S, Lossi A, Nardi G, Marchionni N, Di Mario C, Olivotto I, Perfetto F. Baseline ECG Features and Arrhythmic Profile in Transthyretin Versus Light Chain Cardiac Amyloidosis. Circ Heart Fail. 2020 Mar;13(3):e006619. doi: 10.1161/CIRCHEARTFAILURE.119.006619.
68. Di Filippo C, Caniato F, Cappelli F, Mattesini A, Meucci F, Sori A, Stolcova M, Agostini C, Bernardo P, Di Mario C. Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty: a case report. J Cardiovasc Med (Hagerstown). 2020 Jul 17. doi: 10.2459/JCM.0000000000001042.
69. Cappelli F, Perfetto F, Martone R, Di Mario C. Cardiac amyloidosis in patient undergoing TAVR, why we need to think about it. Cardiovasc Revasc Med. 2020 Jun 10:S1553-8389(20)30354-7. doi: 10.1016/j.carrev.2020.06.005.
70. Russo M, Obici L, Bartolomei I, Cappelli F, Luigetti M, Fenu S, Cavallaro T, Chiappini MG, Gemelli C, Pradotto LG, Manganelli F, Leonardi L, My F, Sampaolo S, Briani C, Gentile L, Stancanelli C, Di Buduo E, Pacciolla P, Salvi F, Casagrande S, Bisogni G, Calabrese D, Vanoli F, Di Iorio G, Antonini G, Santoro L, Mauro A, Grandis M, Di Girolamo M, Fabrizi GM, Pareyson D, Sabatelli M, Perfetto F, Rapezzi C, Merlini G, Mazzeo A, Vita G. ATTRv amyloidosis Italian Registry: clinical and epidemiological data. Amyloid. 2020 Jul 22:1-7. doi:10.1080/13506129.2020.1794807.
71. Ciabatti M, Fumagalli C, Beltrami M, Vignini E, Martinese L, Tomberli A, Zampieri M, Bertini A, Carrassa G, Marchi A, Berteotti M, Cappelli F, Bolognese L, Pieroni M, Olivotto I. Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy. Int J Cardiol. 2020 Nov 1;318:94-100. doi: 10.1016/j.ijcard.2020.07.036.
72. Antonioli E, Staderini M, Pilerci S, Perfetto F, Cappelli F, Allinovi M,Nozzoli C, Attucci I, Buzzichelli A, Messeri M, Bosi A. Daratumumab,lenalidomide, and dexamethasone combination in relapsed/refractory myelomapatients: a real-life single-center experience. Leuk Lymphoma. 2020 Aug 10:1-4.doi: 10.1080/10428194.2020.1802452.
73. Bartolini S, Baldasseroni S, Fattirolli F, Silverii MV, Piccioli L, Perfetto F, Marchionni N, Di Mario C, Martone R, Taborchi G, Morini S, Vignini E, Cappelli F. Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients.Intern Emerg Med. 2020 Sep 12. doi: 10.1007/s11739-020-02474-1.
74. Pontecorboli G, Lagi F, Bagli M, De Vito E, Millotti G, Botta A, Cappelli F, Mattesini A, Acquafresca M, Barletta G, Del Bene R, Colagrande S, Marcucci R, Bartoloni A, Di Mario C, Martinelli CV. Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients. Infez Med. 2020 Sep 1;28(3):397-406.
75. Perfetto F, Casagrande S, Barilaro A, Di Gioia M, Santi R, Allinovi M, Romoli S, Boschi A, Desideri I, Taborchi G, Ungar A, Cappelli F. Progressive and atypical neurological symptoms in refractory systemic AL amyloidosis. Intern Emerg Med. 2020 Sep 14. doi: 10.1007/s11739-020-02489-8.
76. Cappelli F, Tini G, Russo D, Emdin M, Del Franco A, Vergaro G, Di Bella G, Mazzeo A, Canepa M, Volpe M, Perfetto F, Autore C, Di Mario C, Rapezzi C, Musumeci MB. Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation. Amyloid. 2020 Sep 28:1-7. doi: 10.1080/13506129.2020.1798922.
77. Aquaro GD, Morini S, Grigoratos C, Taborchi G, Di Bella G, Martone R, Vignini E, Emdin M, Olivotto I, Perfetto F, Cappelli F. Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates. Int J Cardiol Heart Vasc. 2020 Sep 14;31:100633. doi: 10.1016/j.ijcha.2020.100633.
78. Zampieri M, Nardi G, Del Monaco G, Allinovi M, Gabriele M, Zocchi C, Casagrande S, Fumagalli C, Di Mario C, Olivotto I, Perfetto F, Cappelli F. Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany. Int J Cardiol. 2021 Apr 15:S0167-5273(21)00659-8. doi: 10.1016/j.ijcard.2021.04.023. Epub ahead of print. PMID: 33865873.
79. Magliano L, Obici L, Sforzini C, Mazzeo A, Russo M, Cappelli F, Fenu S, Luigetti M, Tagliapietra M, Gemelli C, Leonardi L, Tozza S, Pradotto LG, Citarelli G, Mauro A, Manganelli F, Antonini G, Grandis M, Fabrizi GM, Sabatelli M, Pareyson D, Perfetto F, Merlini G, Vita G; ATTRv Collaborators. Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy. Orphanet J Rare Dis. 2021 Apr 7;16(1):163. doi: 10.1186/s13023-021-01812-6. PMID: 33827635; PMCID: PMC8028211.
80. Zampieri M, Cappelli F, Allinovi M, Olivotto I, Antonioli E, Tassetti L, Zocchi C, Andrei V, Di Mario C, Nozzoli C, Curciarello G, Ciciani AM, Bergesio F, Vannucchi AM, Perfetto F. Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study. Amyloid. 2021 Mar 10:1-2. doi: 10.1080/13506129.2021.1898365. Epub ahead of print. PMID: 33715557.
81. Cappelli F, Zampieri M, Fumagalli C, Nardi G, Del Monaco G, Matucci Cerinic M, Allinovi M, Taborchi G, Martone R, Gabriele M, Ungar A, Moggi Pignone A, Marchionni N, Di Mario C, Olivotto I, Perfetto F. Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype. J Intern Med. 2021 Jun;289(6):831-839. doi: 10.1111/joim.13200. Epub 2020 Dec 8. PMID: 33615623.
82. Grandis M, Obici L, Luigetti M, Briani C, Benedicenti F, Bisogni G, Canepa M, Cappelli F, Danesino C, Fabrizi GM, Fenu S, Ferrandes G, Gemelli C, Manganelli F, Mazzeo A, Melchiorri L, Perfetto F, Pradotto LG, Rimessi P, Tini G, Tozza S, Trevisan L, Pareyson D, Mandich P. Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus. Orphanet J Rare Dis. 2020 Dec 14;15(1):348. doi: 10.1186/s13023-020-01633-z.
83. Girolami F, Vergaro G, Pieroni M, Passantino S, Giannotti G, Grippo G, Canale ML, Favilli S, Cappelli F, Olivotto I, Casolo G. Percorso clinico proposto dall’ANMCO Toscana per la diagnosi genetica delle cardiomiopatie in un sistema assistenziale in rete [Clinical pathway for cardiomyopathies: a genetic testing strategy proposed by ANMCO in Tuscany]. G Ital Cardiol (Rome). 2020 Dec;21(12):926-934. Italian. doi: 10.1714/3472.34547.
84. Argirò A, Zampieri M, Berteotti M, Marchi A, Tassetti L, Zocchi C, Iannone L, Bacchi B, Cappelli F, Stefàno P, Marchionni N, Olivotto I. Emerging Medical Treatment for Hypertrophic Cardiomyopathy. J Clin Med. 2021 Mar 1;10(5):951. doi: 10.3390/jcm10050951. PMID: 33804412; PMCID: PMC7957690.
85. Zampieri M, Allinovi M, Olivotto I, Antonioli E, Gabriele M, Argirò A, Fumagalli C, Nardi G, Di Mario C, Vannucchi AM, Perfetto F, Cappelli F. Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? Br J Haematol. 2021 May;193(4):e27-e31. doi: 10.1111/bjh.17399. Epub 2021 Apr 11. PMID: 33840100.
86. Zampieri M, Nardi G, Del Monaco G, Allinovi M, Gabriele M, Zocchi C, Casagrande S, Fumagalli C, Di Mario C, Olivotto I, Perfetto F, Cappelli F. Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany. Int J Cardiol. 2021 Jul 15;335:123-127. doi: 10.1016/j.ijcard.2021.04.023. Epub 2021 Apr 15. PMID: 33865873.
87. Aimo A, Rapezzi C, Perfetto F, Cappelli F, Palladini G, Obici L, Merlini G, Di Bella G, Serenelli M, Zampieri M, Milani P, Licordari R, Teresi L, Ribarich N, Castiglione V, Quattrone F, De Rosis S, Vergaro G, Panichella G, Emdin M, Passino C. Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis. Eur J Clin Invest. 2021 Nov;51(11):e13598. doi: 10.1111/eci.13598. Epub 2021 May 22. PMID: 33982288.
88. Tini G, Cappelli F, Biagini E, Musumeci B, Merlo M, Crotti L, Cameli M, Di Bella G, Cipriani A, Marzo F, Guerra F, Forleo C, Gagliardi C, Zampieri M, Carigi S, Vianello PF, Mandoli GE, Ciliberti G, Lichelli L, Mariani D, Porcari A, Russo D, Licordari R, Ponziani A, Porto I, Perfetto F, Autore C, Rapezzi C, Sinagra G, Canepa M. Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey. ESC Heart Fail. 2021 Aug;8(4):3369-3374. doi: 10.1002/ehf2.13411. Epub 2021 May 14.
89. Zampieri M, Berteotti M, Ferrantini C, Tassetti L, Gabriele M, Tomberli B, Castelli G, Cappelli F, Stefàno P, Marchionni N, Coppini R, Olivotto I. Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives. Curr Heart Fail Rep. 2021 Aug;18(4):169-179. doi: 10.1007/s11897-021-00523-0. Epub 2021 Jun 20. PMID: 34148184.
90. Emdin M, Perfetto F, Aimo A, Vergaro G, Buda G, Cappelli F, Pieroni M, Grippo G, Sorini Dini C, Canale ML, Olivotto I, Cameli M, Casolo G. Percorso clinico-assistenziale in rete per la diagnosi e la gestione del paziente con amiloidosi cardiaca. Documento di consenso ANMCO Toscana e SIC Tosco-Umbra [Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC)]. G Ital Cardiol (Rome). 2021 Aug;22(8):621-634. Italian. doi: 10.1714/3641.36218.
91. Caniato F, Andrei V, Bernardo P, Agostini C, Cappelli F, Stefano PL, Olivotto I, Pieroni M, Bolognese L, Di Mario C. Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy Plus Apical Ballooning: Management With VA-ECMO and Myectomy. JACC Case Rep. 2021 Mar 17;3(3):433-437. doi: 10.1016/j.jaccas.2020.11.029. PMID: 34317552; PMCID: PMC8311032.
92. Fumagalli C, Zampieri M, Perfetto F, Zocchi C, Maurizi N, Tassetti L, Ungar A, Gabriele M, Nardi G, Del Monaco G, Baldini K, Tomberli A, Tomberli B, Marchionni N, Di Mario C, Olivotto I, Cappelli F. Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis. Mayo Clin Proc. 2021 Aug;96(8):2185-2191. doi: 10.1016/j.mayocp.2021.04.021. PMID: 34353472.
93. Bandera F, Martone R, Chacko L, Ganesananthan S, Gilbertson JA, Ponticos M, Lane T, Martinez-Naharro A, Whelan C, Quarta C, Rowczenio D, Patel R, Razvi Y, Lachmann H, Wechelakar A, Brown J, Knight D, Moon J, Petrie A, Cappelli F, Guazzi M, Potena L, Rapezzi C, Leone O, Hawkins PN, Gillmore JD, Fontana M. Clinical Importance of  left Atrial Infiltration in Cardiac Transthyretin Amyloidosis. JACC Cardiovasc Imaging. 2021 Aug 11:S1936-878X(21)00512-X. doi: 10.1016/j.jcmg.2021.06.022. Epub ahead of print. PMID: 34419399.
94. Merlo M, Porcari A, Pagura L, Cameli M, Vergaro G, Musumeci B, Biagini E, Canepa M, Crotti L, Imazio M, Forleo C, Cappelli F, Favale S, Di Bella G, Dore F, Lombardi CM, Pavasini R, Rella V, Palmiero G, Caiazza M, Albanese M, Guaricci AI, Branzi G, Caponetti AG, Saturi G, La Malfa G, Merlo AC, Andreis A, Bruno F, Longo F, Sfriso E, Di Ienno L, De Carli G, Giacomin E, Spini V, Milidoni A, Limongelli G, Autore C, Olivotto I, Badano L, Parati G, Perlini S, Metra M, Emdin M, Rapezzi C, Sinagra G. A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study. Eur J Prev Cardiol. 2021 Sep 9:zwab127. doi: 10.1093/eurjpc/zwab127. Epub ahead of print. PMID: 34499711.
95. Tassetti L, Girolami F, Fumagalli C, Argirò A, Ricciardi G, Checchi L, Zocchi C, Berteotti M, Tomberli B, Gabrielli E, Favilli S, Pieroni M, Cappelli F, Tanini I, Pieragnoli P, Marchionni N, Olivotto I. Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing. Circ Arrhythm Electrophysiol. 2021 Dec;14(12):e010562. doi: 10.1161/CIRCEP.121.010562. Epub 2021 Nov 24. PMID: 34814702.
96. Argirò A, Rosenblum H, Griffin J, Batra J, Cappelli F, Burkhoff D, Maurer M, Olivotto I. Sex related differences in exercise performance in patients with hypertrophic cardiomyopathy: Hemodynamic insights through non-invasive pressure volume analysis. Int J Cardiol. 2021 Dec 28:S0167-5273(21)02048-9. doi: 10.1016/j.ijcard.2021.12.045. Epub ahead of print. PMID: 34968627.
97. Batra J, Rosenblum H, Cappelli F, Zampieri M, Olivotto I, Griffin JM, Saith SE, Teruya S, De Los Santos J, Argiro A, Burkhoff D, Perfetto F, Maurer MS. Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis. J Card Fail. 2021 Dec 30:S1071-9164(21)00527-3. doi: 10.1016/j.cardfail.2021.12.016. Epub ahead of print. PMID: 34974181.
98. Zampieri M, Argirò A, Allinovi M, Tassetti L, Zocchi C, Gabriele M, Andrei V, Fumagalli C, Di Mario C, Tomberli A, Olivotto I, Perfetto F, Cappelli F. Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis. Int J Cardiol. 2022 Jan 4:S0167-5273(21)02051-9. doi: 10.1016/j.ijcard.2021.12.048. Epub ahead of print. PMID: 34990715.
99. Zampieri M, Argirò A, Allinovi M, Perfetto F, Cappelli F. SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series. Intern Emerg Med. 2022 Feb 8. doi: 10.1007/s11739-022-02944-8.
100. Tassetti L, Fumagalli C, Argirò A, Zampieri M, Gori M, Verrillo F, Zocchi C, Cappelli F, Olivotto I. Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease. J Cardiovasc Electrophysiol. 2022 Feb 9. doi: 10.1111/jce.15409.
101. Perfetto F, Zampieri M, Fumagalli C, Allinovi M, Cappelli F. Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist. Intern Emerg Med. 2022 Mar 24. doi: 10.1007/s11739-022-02958-2.
102. Merlo M, Pagura L, Porcari A, Cameli M, Vergaro G, Musumeci B, Biagini E, Canepa M, Crotti L, Imazio M, Forleo C, Cappelli F, Perfetto F, Favale S, Di Bella G, Dore F, Girardi F, Tomasoni D, Pavasini R, Rella V, Palmiero G, Caiazza M, Carella MC, Igoren Guaricci A, Branzi G, Caponetti AG, Saturi G, La Malfa G, Merlo AC, Andreis A, Bruno F, Longo F, Rossi M, Varrà GG, Saro R, Di Ienno L, De Carli G, Giacomin E, Arzilli C, Limongelli G, Autore C, Olivotto I, Badano L, Parati G, Perlini S, Metra M, Michele E, Rapezzi C, Sinagra G. Unmasking the Prevalence of Amyloid Cardiomyopathy in the Real World: Results from Phase 2 of AC-TIVE Study, an Italian Nationwide Survey. Eur J Heart Fail. 2022 Apr 13. doi: 10.1002/ejhf.2504.
103. Argiro' A, Cappelli F, Di Mario C. Aortic Stenosis and Cardiac Amyloidosis: PARTNERs in Crime? Cardiovasc Revasc Med. 2022 Oct;43:26-27. doi: 10.1016/j.carrev.2022.07.011. Epub 2022 Jul 25. PMID: 35941068.
104. Innocenti S, Bacchi B, Allinovi M, Perfetto F, Antonioli E, Marchionni N, Di Mario C, Caroti L, Cappelli F, Stefàno P. A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis. BMC Nephrol. 2022 Nov 17;23(1):370. doi: 10.1186/s12882-022-02984-4. PMID: 36397026; PMCID: PMC9673363.
105. Silverii MV, Argirò A, Baldasseroni S, Fumagalli C, Zampieri M, Guerrieri L, Bartolini S, Mazzoni C, Burgisser C, Tomberli A, Di Mario C, Marchionni N, Olivotto I, Perfetto F, Fattirolli F, Cappelli F. Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis. Intern Emerg Med. 2022 Nov 18. doi: 10.1007/s11739-022-03125-3. Epub ahead of print. PMID: 36396841.
106. Mazzarotto F, Argirò A, Zampieri M, Magri C, Giotti I, Boschi B, Frusconi S, Gennarelli M, Buxbaum J, Polimanti R, Olivotto I, Perfetto F, Cappelli F. Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy. Eur J Hum Genet. 2022 Nov 15. doi: 10.1038/s41431-022-01235-2. Epub ahead of print. PMID: 36380086.
107. Argirò A, Del Franco A, Mazzoni C, Allinovi M, Tomberli A, Tarquini R, Di Mario C, Perfetto F, Cappelli F, Zampieri M. Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not. Biomedicines. 2022 Nov 10;10(11):2888. doi: 10.3390/biomedicines10112888. PMID: 36359408; PMCID: PMC9687719.
108. Allinovi M, Bergesio F, Cappelli F, Chiappini MG, Santostefano M, Argirò A, Catalucci T, Parise A, Zampieri M, Perfetto F. Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease? Am J Nephrol. 2022 Nov 7:1-4. doi: 10.1159/000526955. Epub ahead of print. PMID: 36349760.
109. Argirò A, Zampieri M, Dei L, Ferrantini C, Marchi A, Tomberli A, Baldini K, Cappelli F, Favilli S, Passantino S, Zocchi C, Tassetti L, Gabriele M, Maurizi N, Marchionni N, Coppini R, Olivotto I. Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center. Int J Cardiol. 2022 Oct 10:S0167-5273(22)01523-6. doi: 10.1016/j.ijcard.2022.10.014. Epub ahead of print. PMID: 36228766.
110. Cipriani A, De Michieli L, Porcari A, Licchelli L, Sinigiani G, Tini G, Zampieri M, Sessarego E, Argirò A, Fumagalli C, De Gaspari M, Licordari R, Russo D, Di Bella G, Perfetto F, Autore C, Musumeci B, Canepa M, Merlo M, Sinagra G, Gregori D, Iliceto S, Perazzolo Marra M, Cappelli F, Rapezzi C. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value. JACC CardioOncol. 2022 Sep 7;4(4):458-470. doi: 10.1016/j.jaccao.2022.08.007. PMID: 36444225; PMCID: PMC9700257.
111. Argiro' A, Zampieri M, Mazzoni C, Catalucci T, Biondo B, Tomberli A, Gabriele M, Di Mario C, Perfetto F, Cappelli F. Red flags for the diagnosis of cardiac amyloidosis: simple suggestions to raise suspicion and achieve earlier diagnosis. J Cardiovasc Med (Hagerstown). 2022 Aug 1;23(8):493-504. doi: 10.2459/JCM.0000000000001337. PMID: 35904994.
112. Gorini F, Santoro M, Pierini A, Mezzasalma L, Baldacci S, Bargagli E, Boncristiano A, Brunetto MR, Cameli P, Cappelli F, Castaman G, Coco B, Donati MA, Guerrini R, Linari S, Murro V, Olivotto I, Parronchi P, Pochiero F, Rossi O, Scappini B, Sodi A, Vannucchi AM, Coi A. Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study. Front Pharmacol. 2022 May 16;13:869842. doi: 10.3389/fphar.2022.869842. PMID: 35652051; PMCID: PMC9148958.
113. Di Bella G, Cappelli F, Licordari R, Piaggi P, Campisi M, Bellavia D, Minutoli F, Gentile L, Russo M, de Gregorio C, Perfetto F, Mazzeo A, Falletta C, Clemenza F, Vita G, Carerj S, Aquaro GD. Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis. Amyloid. 2022 Sep;29(3):197-204. doi: 10.1080/13506129.2022.2064739. Epub 2022 Apr 23. PMID: 35465808.
114. Cappelli F, Cipriani A, Russo D, Tini G, Zampieri M, Zocchi C, Sinigiani G,Tassetti L, Licchelli L, Perfetto F, Autore C, Musumeci MB. Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis. Amyloid. 2022 Sep;29(3):211-212. doi: 10.1080/13506129.2022.2060073. Epub 2022 Apr 22. PMID: 35451897.
115. Aguiar Rosa S, Thomas B, Pieroni M, Maurizi N, Zampieri M, Cappelli F, Marchi A, Pradella S, Cardim N, Bogaert J, Olivotto I. Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama. Int J Cardiovasc Imaging. 2022 Dec 21. doi: 10.1007/s10554-022-02774-x. Epub ahead of print. PMID: 36543912.
116. Perfetto F, Zampieri M, Bandini G, Fedi R, Tarquini R, Santi R, Novelli L, Allinovi M, Argirò A, Cappelli F. Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease. Biomedicines. 2022 Dec 12;10(12):3226. doi: 10.3390/biomedicines10123226. PMID: 36551982; PMCID: PMC9775219.
117. Porcari A, Rossi M, Cappelli F, Canepa M, Musumeci B, Cipriani A, Tini G, Barbati G, Varrà GG, Morelli C, Fumagalli C, Zampieri M, Argirò A, Vianello PF, Sessarego E, Russo D, Sinigiani G, De Michieli L, Di Bella G, Autore C, Perfetto F, Rapezzi C, Sinagra G, Merlo M. (2022). Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis. EUROPEAN JOURNAL OF HEART FAILURE, vol. 24, p. 1227-1236, ISSN: 1388-9842, doi: 10.1002/ejhf.2533
118. Argiro' A., Cappelli F., Di Mario C. (2022). Aortic Stenosis and Cardiac Amyloidosis: PARTNERs in Crime?. CARDIOVASCULAR REVASCULARIZATION MEDICINE, vol. 43, p. 26-27, ISSN: 1553-8389, doi: 10.1016/j.carrev.2022.07.011
119. Canepa M., Cappelli F., Limongelli G., Luigetti M., Manganelli F., Mazzeo A., Pareyson D., Perlini S., Obici L. (2022). The proper management of the patient with hereditary transthyretin amyloidosis with mixed phenotype: recommendations from a group of Italian experts. DRUGS IN CONTEXT, vol. 11, p. 1-11, ISSN: 1740-4398, doi: 10.7573/dic.2022-3-7
120. Zampieri M, Salvi S, Fumagalli C, Argirò A, Zocchi C, Del Franco A, Iannaccone G, Giovani S, Ferrantini C, Palinkas ED, Cappelli F, Olivotto I. Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation. Int J Cardiol. 2023 Jan 5:S0167-5273(22)01981-7. doi: 10.1016/j.ijcard.2022.12.056. Epub ahead of print. PMID: 36621577.
121. Ponti L, Smorti M, Pozza F, Argirò A, Zampieri M, Mazzoni C, Gabriele M, Mario CD, Olivotto I, Perfetto F, Cappelli F. Anxious/Depressive Symptoms Alter the Subjective Perception of Heart Failure Severity in Transthyretin Cardiac Amyloidosis. Am J Cardiol. 2023 Jan 21;192:1-6. doi: 10.1016/j.amjcard.2023.01.007.
122. Sinagra G, Emdin M, Merlo M, Vergaro G, Aimo A, Biagini E, Imazio M, Porcari A, Limongelli G, Cipriani A, Canepa M, Musumeci B, Cameli M, Crotti L, Di Bella G, Di Lenarda A, Cappelli F, Chimenti C, Obici L, Iacoviello M, Perlini S, Pieroni M, Metra M, Oliva F, Perrone Filardi P, Colivicchi F, Indolfi C. Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca [Rationale and significance of the Italian Network for Cardiac Amyloidosis]. G Ital Cardiol (Rome). 2023 Feb;24(2):93-98. Italian. doi: 10.1714/3963.39416.
123. Smorti M, Ponti L, Soffio F, Argirò A, Perfetto F, Zampieri M, Mazzoni C, Tomberli A, Allinovi M, Di Mario C, Olivotto I, Cappelli F. Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis. Front Psychol. 2023 Jan 18;13:1066224. doi: 10.3389/fpsyg.2022.1066224.
124. Tini G, Milani P, Zampieri M, Caponetti AG, Fabris F, Foli A, Argirò A, Mazzoni C, Gagliardi C, Longhi S, Saturi G, Vergaro G, Aimo A, Russo D, Varrà GG, Serenelli M, Fabbri G, De Michieli L, Palmiero G, Ciliberti G, Carigi S, Sessarego E, Mandoli GE, Ricci Lucchi G, Rella V, Monti E, Gardini E, Bartolotti M, Crotti L, Merli E, Mussinelli R, Vianello PF, Cameli M, Marzo F, Guerra F, Limongelli G, Cipriani A, Perlini S, Obici L, Perfetto F, Autore C, Porto I, Rapezzi C, Sinagra G, Merlo M, Musumeci B, Emdin M, Biagini E, Cappelli F, Palladini G, Canepa M. Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study. Eur J Heart Fail. 2023 Mar 12. doi: 10.1002/ejhf.2823. Epub ahead of print. PMID: 36907828.
125. Rauf MU, Hawkins PN, Cappelli F, Perfetto F, Zampieri M, Argiro A, Petrie A, Law S, Porcari A, Razvi Y, Bomsztyk J, Ravichandran S, Ioannou A, Patel R, Starr N, Hutt DF, Mahmood S, Wisniowski B, Martinez-Naharro A, Venneri L, Whelan C, Roczenio D, Gilbertson J, Lachmann HJ, Wechalekar AD, Rapezzi C, Serenelli M, Massa P, Caponetti AG, Ponziani A, Accietto A, Giovannetti A, Saturi G, Sguazzotti M, Gagliardi C, Biagini E, Longhi S, Fontana M, Gillmore JD. Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis. Eur Heart J. 2023 Mar 22:ehad139. doi: 10.1093/eurheartj/ehad139. Epub ahead of print. PMID: 36946431.
126. Cappelli F, Del Franco A, Vergaro G, Mazzoni C, Argirò A, Pieroni M, Giacomin E, Poli S, Allinovi M, Olivotto I, Pieroni F, Scaletti C, Emdin M, Perfetto F. Prevalence of transthyretin-related amyloidosis in Tuscany: Data from the regional population-based registry. Int J Cardiol. 2023 Mar 31:S0167-5273(23)00475-8. doi: 10.1016/j.ijcard.2023.03.063. Epub ahead of print. PMID: 37004943.
127. Fumagalli C, Bonanni F, Beltrami M, Ruggieri R, Zocchi C, Tassetti L, Maurizi N, Berteotti M, Zampieri M, Argirò A, Lovero F, Tomberli A, di Bari M, Marchionni N, Pieragnoli P, Ricciardi G, Checchi L, Cappelli F, Fumagalli S, Olivotto I. Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring. Int J Cardiol. 2023 Apr 13:S0167-5273(23)00523-5. doi: 10.1016/j.ijcard.2023.04.008. Epub ahead of print. PMID: 37061097.
128. Argirò, Alessia, Zampieri, Mattia, Marchi, Alberto, Cappelli, Francesco, Del Franco, Annamaria, Mazzoni, Carlotta, Cecchi, Franco, Olivotto, Iacopo (2023). Stage-specific therapy for hypertrophic cardiomyopathy. EUROPEAN HEART JOURNAL SUPPLEMENTS, vol. 25, p. 155-161, ISSN: 1554-2815, doi: 10.1093/eurheartjsupp/suad042
129. Fumagalli C, Smorti M, Ponti L, Pozza F, Argirò A, Credi G, Di Mario C, Marfella R, Marchionni N, Olivotto I, Perfetto F, Ungar A, Cappelli F. Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis. Aging Clin Exp Res. 2023 May 2. doi: 10.1007/s40520-023-02419-6. Epub ahead of print. PMID: 37129709.
130. Fumagalli C, Zocchi C, Cappelli F, Celata A, Tassetti L, Sasso L, Zampieri M, Argirò A, Marchi A, Targetti M, Berteotti M, Maurizi N, Mori F, Livi P, Baldini K, Tomberli A, Girolami F, Favilli S, Mecacci F, Olivotto I. Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy. Eur J Prev Cardiol. 2023 Aug 2:zwad257. doi: 10.1093/eurjpc/zwad257.
131. Caniato F, Lazzeri C, Bonizzoli M, Mattesini A, Batacchi S, Cappelli F, Di Mario C, Peris A. Urgent coronary angiography in out-of-hospital cardiac arrest: a retrospective single centre investigation. J Cardiovasc Med (Hagerstown). 2023 Sep 1;24(9):637-641. doi: 10.2459/JCM.0000000000001510.
132. Aimo A, Teresi L, Castiglione V, Picerni AL, Niccolai M, Severino S, Agazio A, Carnevale Baraglia A, Obici L, Palladini G, Ponti L, Argirò A, Cappelli F, Perfetto F, Serenelli M, Trimarchi G, Licordari R, Di Bella G, Chubuchna O, Quattrone F, Nuti S, De Rosis S, Passino C, Rapezzi C, Merlini G, Emdin M, Vergaro G. Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study. Amyloid. 2023 Sep 5:1-10. doi: 10.1080/13506129.2023.2254451.
133. Fumagalli C, Zampieri M, Argirò A, Tassetti L, Rossi G, Musumeci B, Tini G, Russo D, Sclafani M, Cipriani A, Sinigiani G, Di Bella G, Licordari R, Canepa M, Vianello PF, Merlo M, Porcari A, Rossi M, Sinagra G, Rapezzi C, Di Mario C, Ungar A, Olivotto I, Perfetto F, Cappelli F. Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis. Int J Cardiol. 2023 Dec 1;392:131346. doi: 10.1016/j.ijcard.2023.131346. Epub 2023 Sep 7.
134. Russo D, Cappelli F, Di Bella G, Tini G, Porcari A, Cipriani A, Canepa M, Merlo M, Licordari R, Vianello PF, Zampieri M, De Michieli L, Scirpa R, Perfetto F, Sinagra G, Autore C, Rapezzi C, Musumeci MB. Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations. Int J Cardiol. 2023 Dec 15;393:131354. doi: 10.1016/j.ijcard.2023.131354.
135. Ponti L, Hsu K, Damy T, Villacorta E, Verheyen N, Keohane D, Wang R, Ines M, Kumar N, Munteanu C, Cappelli F. Burden of untreated transthyretin amyloid cardiomyopathy on patients and their caregivers by disease severity: results from a multicenter, non-interventional, real-world study. Front Cardiovasc Med. 2023 Aug 29;10:1238843. doi: 10.3389/fcvm.2023.1238843.
136. Argirò A, Zampieri M, Marchi A, Del Franco A, Pàlinkàs ED, Biagioni G, Chiti C, Mazzoni C, Fornaro A, Targetti M, Cappelli F, Olivotto I. Approcci terapeutici nella cardiomiopatia ipertrofica: dal controllo dei sintomi alla terapia di precisione [Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy]. G Ital Cardiol (Rome). 2023 Oct;24(10):792-799. Italian. doi: 10.1714/4100.40979. PMID: 37767831.
137. Del Franco A, Iannaccone G, Meucci MC, Lillo R, Cappelli F, Zocchi C, Pieroni M, Graziani F, Olivotto I. Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal. Heart Fail Rev. 2023 Nov 25. doi: 10.1007/s10741-023-10370-x. Epub ahead of print. PMID: 38006470.
138. Argirò A, Silverii MV, Burgisser C, Fattirolli F, Baldasseroni S, di Mario C, Zampieri M, Biagioni G, Mazzoni C, Chiti C, Allinovi M, Ungar A, Perfetto F, Cappelli F. Serial Changes in Cardiopulmonary Exercise Testing Parameters in Untreated Patients With Transthyretin Cardiac Amyloidosis. Can J Cardiol. 2023 Oct 2:S0828-282X(23)01745-2. doi: 10.1016/j.cjca.2023.09.028. Epub ahead of print. PMID: 37793568.
139. Del Franco A, Biagioni G, Mazzoni C, Cappelli F. Amyloidosis in spinal stenosis: How, when and whether cardiac screening has a clinical impact. Int J Cardiol. 2024 Jan 15;395:131413. doi: 10.1016/j.ijcard.2023.131413. Epub 2023 Oct 5. PMID: 37802296.